firstpost_date,url,trackback_author_nick,content,score,trackback_permalink,trackback_author_url
06/01/14,http://twitter.com/jnci_now/status/473067700332154880,jnci_now,Bevacizumab &amp; chemotherapy &amp; cetuximab plus chemotherapy – are equally effective for patients w/ MCRC and no KRAS mutations. #CRCSM #ASCO14,7.898145,http://twitter.com/JNCI_Now/status/473067700332154880,http://twitter.com/jnci_now
06/01/14,http://twitter.com/jnci_now/status/473068956073205760,jnci_now,"“About 75% of patients w/ MCRC in U.S initially receive bevacizumab-based therapy.""-Alan P. Venook, MD #CRCSM #ASCO14",6.7901273,http://twitter.com/JNCI_Now/status/473068956073205760,http://twitter.com/jnci_now
06/01/14,http://twitter.com/jnci_now/status/473068956907864065,jnci_now,"Approx. 50,000 Americans are diagnosed with MCRC each year. #CRCSM #ASCO14",7.4127893,http://twitter.com/JNCI_Now/status/473068956907864065,http://twitter.com/jnci_now
06/01/14,http://twitter.com/jnci_now/status/473068959642562560,jnci_now,"Cetuximab targets EGFR, a protein involved in cancer growth and spread. #CRCSM #ASCO14",7.336216,http://twitter.com/JNCI_Now/status/473068959642562560,http://twitter.com/jnci_now
06/01/14,http://twitter.com/jnci_now/status/473068958765940736,jnci_now,"Bevacizumab targets VEGF, blocking the development of blood vessels that tumors need to grow. #CRCSM #ASCO14",7.0938053,http://twitter.com/JNCI_Now/status/473068958765940736,http://twitter.com/jnci_now
06/01/14,http://twitter.com/cancerdotnet/status/473069346777231360,cancerdotnet,"Just released! Patient summaries on #ASCO14 highlights on breast, colorectal, &amp; prostate ca #pcsm #crcsm #bcsm http://t.co/SSOL3MmvXY",6.899926,http://twitter.com/CancerDotNet/status/473069346777231360,http://twitter.com/cancerdotnet
06/01/14,http://twitter.com/jnci_now/status/473070213651767297,jnci_now,"“With this finding, oncologists and patients have more ways to personalize cancer treatment,” -Clifford A. Hudis, MD, FACP #CRCSM #ASCO14",7.059095,http://twitter.com/JNCI_Now/status/473070213651767297,http://twitter.com/jnci_now
06/01/14,http://twitter.com/jnci_now/status/473070212334374914,jnci_now,Bevacizumab w/ FOLFOX is widely used in the U.S. while cetuximab-based regimens tend to be used more frequently in Europe. #CRCSM #ASCO14,6.8190737,http://twitter.com/JNCI_Now/status/473070212334374914,http://twitter.com/jnci_now
06/01/14,http://twitter.com/jnci_now/status/473070214767067136,jnci_now,"“They can be reassured that two widely used regimens offer good and equivalent survival.” Clifford A. Hudis, MD, FACP #CRCSM #ASCO14",7.018774,http://twitter.com/JNCI_Now/status/473070214767067136,http://twitter.com/jnci_now
06/01/14,http://twitter.com/swog/status/473070514165272576,swog,"Bevacizumab, cetuximab equally effective when added to chemo 4 metastatic CRC w/o KRAS mutat #ASCO14 #SWOGonc http://t.co/KpdwPDfvwS #CRCSM",6.870724,http://twitter.com/SWOG/status/473070514165272576,http://twitter.com/swog
06/01/14,http://twitter.com/asco/status/473071452854681600,asco,"#ASCO14 plenary briefing features advances in breast, prostate, colorectal cancer treatment http://t.co/azAXaByfaJ #bcsm #pcsm #crcsm",12.834448,http://twitter.com/ASCO/status/473071452854681600,http://twitter.com/asco
06/01/14,http://twitter.com/swog/status/473072649191837696,swog,"Good summary 4 patients: CALGB/#SWOGonc 80405 results (bevacizumab, cetuximab both effective w chemo in mCRC) http://t.co/minlzgpnDw #CRCSM",11.219838,http://twitter.com/SWOG/status/473072649191837696,http://twitter.com/swog
06/01/14,http://twitter.com/dmooneymd/status/473073301477015553,dmooneymd,"RT @ASCO: #ASCO14 plenary briefing features advances in breast, prostate, colorectal cancer treatment http://t.co/azAXaByfaJ #bcsm #pcsm #c…",6.920505,http://twitter.com/dmooneymd/status/473073301477015553,http://twitter.com/dmooneymd
06/01/14,http://twitter.com/penrynpam/status/473074473110077440,penrynpam,"RT @ASCO: #ASCO14 plenary briefing features advances in breast, prostate, colorectal cancer treatment http://t.co/azAXaByfaJ #bcsm #pcsm #c…",6.920505,http://twitter.com/PenrynPam/status/473074473110077440,http://twitter.com/penrynpam
06/01/14,http://twitter.com/lollycabbage81/status/473075629861380097,lollycabbage81,"RT @ASCO: #ASCO14 plenary briefing features advances in breast, prostate, colorectal cancer treatment http://t.co/azAXaByfaJ #bcsm #pcsm #c…",6.920505,http://twitter.com/Lollycabbage81/status/473075629861380097,http://twitter.com/lollycabbage81
06/01/14,http://twitter.com/palliverse/status/473084890334760960,palliverse,"RT @ASCO: #ASCO14 plenary briefing features advances in breast, prostate, colorectal cancer treatment http://t.co/azAXaByfaJ #bcsm #pcsm #c…",6.920505,http://twitter.com/palliverse/status/473084890334760960,http://twitter.com/palliverse
06/01/14,http://twitter.com/equicarehealth/status/473085986902396928,equicarehealth,"RT @ASCO: #ASCO14 plenary briefing features advances in breast, prostate, colorectal cancer treatment http://t.co/azAXaByfaJ #bcsm #pcsm #c…",6.920505,http://twitter.com/EquicareHealth/status/473085986902396928,http://twitter.com/equicarehealth
06/01/14,http://twitter.com/ravi770365/status/473086728341704704,ravi770365,RT @JNCI_Now: Bevacizumab &amp; chemotherapy &amp; cetuximab plus chemotherapy – are equally effective for patients w/ MCRC and no KRAS mutations. …,6.4599752,http://twitter.com/ravi770365/status/473086728341704704,http://twitter.com/ravi770365
06/01/14,http://twitter.com/shewithlynch/status/473092366153166848,shewithlynch,"RT @ASCO: #ASCO14 plenary briefing features advances in breast, prostate, colorectal cancer treatment http://t.co/azAXaByfaJ #bcsm #pcsm #c…",6.920505,http://twitter.com/ShewithLynch/status/473092366153166848,http://twitter.com/shewithlynch
06/01/14,http://twitter.com/z_phd/status/473093581893550080,z_phd,RT @JNCI_Now: Bevacizumab &amp; chemotherapy &amp; cetuximab plus chemotherapy – are equally effective for patients w/ MCRC and no KRAS mutations. …,6.4599752,http://twitter.com/z_phd/status/473093581893550080,http://twitter.com/z_phd
06/01/14,http://twitter.com/asco/status/473095451466797056,asco,"Plenary press brief #ASCO14: Bevacizumab + chemo and cetuximab + chemo were equally effective, no meaningful diff. in survival. #crcsm",12.89884,http://twitter.com/ASCO/status/473095451466797056,http://twitter.com/asco
06/01/14,http://twitter.com/aftimosp/status/473095542558695424,aftimosp,"RT @ASCO: Plenary press brief #ASCO14: Bevacizumab + chemo and cetuximab + chemo were equally effective, no meaningful diff. in survival. #…",6.8218465,http://twitter.com/aftimosp/status/473095542558695424,http://twitter.com/aftimosp
06/01/14,http://twitter.com/kanghoko/status/473095910600093696,kanghoko,"RT @ASCO: Plenary press brief #ASCO14: Bevacizumab + chemo and cetuximab + chemo were equally effective, no meaningful diff. in survival. #…",6.8218465,http://twitter.com/KanghoKo/status/473095910600093696,http://twitter.com/kanghoko
06/01/14,http://twitter.com/drcbsteer/status/473096158693580800,drcbsteer,"RT @ASCO: Plenary press brief #ASCO14: Bevacizumab + chemo and cetuximab + chemo were equally effective, no meaningful diff. in survival. #…",6.8218465,http://twitter.com/drcbsteer/status/473096158693580800,http://twitter.com/drcbsteer
06/01/14,http://twitter.com/cmi0309/status/473096360317554688,cmi0309,"RT @ASCO: Plenary press brief #ASCO14: Bevacizumab + chemo and cetuximab + chemo were equally effective, no meaningful diff. in survival. #…",6.8218465,http://twitter.com/cmi0309/status/473096360317554688,http://twitter.com/cmi0309
06/01/14,http://twitter.com/bkfviking123/status/473096700223946752,bkfviking123,"RT @ASCO: Plenary press brief #ASCO14: Bevacizumab + chemo and cetuximab + chemo were equally effective, no meaningful diff. in survival. #…",6.8218465,http://twitter.com/bkfViking123/status/473096700223946752,http://twitter.com/bkfviking123
06/01/14,http://twitter.com/dr_fpetracci/status/473097180778356736,dr_fpetracci,"RT @ASCO: Plenary press brief #ASCO14: Bevacizumab + chemo and cetuximab + chemo were equally effective, no meaningful diff. in survival. #…",6.8218465,http://twitter.com/dr_FPetracci/status/473097180778356736,http://twitter.com/dr_fpetracci
06/01/14,http://twitter.com/zizo_mb/status/473097309841293312,zizo_mb,"RT @ASCO: #ASCO14 plenary briefing features advances in breast, prostate, colorectal cancer treatment http://t.co/azAXaByfaJ #bcsm #pcsm #c…",6.920505,http://twitter.com/zizo_mb/status/473097309841293312,http://twitter.com/zizo_mb
06/01/14,http://twitter.com/drdeepakg/status/473099037093023745,drdeepakg,"RT @ASCO: Plenary press brief #ASCO14: Bevacizumab + chemo and cetuximab + chemo were equally effective, no meaningful diff. in survival. #…",6.8218465,http://twitter.com/drdeepakg/status/473099037093023745,http://twitter.com/drdeepakg
06/01/14,http://twitter.com/asco/status/473101997911330816,asco,"Before the Colorectal Cancer session at #ASCO14, read up on the GI Symposium: http://t.co/bB3Zh59YVy #crcsm #ASCOConnection",11.570172,http://twitter.com/ASCO/status/473101997911330816,http://twitter.com/asco
06/01/14,http://twitter.com/mtmdphd/status/473102601680994304,mtmdphd,"RT @ASCO: Before the Colorectal Cancer session at #ASCO14, read up on the GI Symposium: http://t.co/bB3Zh59YVy #crcsm #ASCOConnection",10.338758,http://twitter.com/mtmdphd/status/473102601680994304,http://twitter.com/mtmdphd
06/01/14,http://twitter.com/fwpharma/status/473103070126419969,fwpharma,"RT @ASCO: #ASCO14 plenary briefing features advances in breast, prostate, colorectal cancer treatment http://t.co/azAXaByfaJ #bcsm #pcsm #c…",10.087501,http://twitter.com/fwpharma/status/473103070126419969,http://twitter.com/fwpharma
06/01/14,http://twitter.com/benjcrousseau/status/473111789786263553,benjcrousseau,"RT @ASCO: Plenary press brief #ASCO14: Bevacizumab + chemo and cetuximab + chemo were equally effective, no meaningful diff. in survival. #…",6.8218465,http://twitter.com/BenjcRousseau/status/473111789786263553,http://twitter.com/benjcrousseau
06/01/14,http://twitter.com/aakonc/status/473114207484129280,aakonc,"RT @ASCO: Plenary press brief #ASCO14: Bevacizumab + chemo and cetuximab + chemo were equally effective, no meaningful diff. in survival. #…",6.8218465,http://twitter.com/aakonc/status/473114207484129280,http://twitter.com/aakonc
06/01/14,http://twitter.com/aakonc/status/473114726117822465,aakonc,“@rschilsky: #ASCO14 CALGB/SWOG 80405 shows 29 mo. median OS in both arms. Bev and cetux equivalent.” OS results best news from study#crcsm,6.732894,http://twitter.com/aakonc/status/473114726117822465,http://twitter.com/aakonc
06/01/14,http://twitter.com/fightcrc/status/473118961794838529,fightcrc,A new consensus group (CRCSC) will help advance a biologic understanding of #coloncancer! #ASCO14 #crcsm,11.28917,http://twitter.com/FightCRC/status/473118961794838529,http://twitter.com/fightcrc
06/01/14,http://twitter.com/fightcrc/status/473119749858418689,fightcrc,Research trends toward gene expression profiles of different sub types of CRC- what we're hearing at #ASCO14 #crcsm,12.08868,http://twitter.com/FightCRC/status/473119749858418689,http://twitter.com/fightcrc
06/01/14,http://twitter.com/hcaoncnursenav/status/473119867005333505,hcaoncnursenav,RT @FightCRC: Research trends toward gene expression profiles of different sub types of CRC- what we're hearing at #ASCO14 #crcsm,7.0640936,http://twitter.com/HCAOncNurseNav/status/473119867005333505,http://twitter.com/hcaoncnursenav
06/01/14,http://twitter.com/cancerdotnet/status/473120605248946177,cancerdotnet,Podcast: @ASCO President Dr. Clifford Hudis @CliffordHudis on today's #ASCO14 research #brsm #crcsm #pcsm http://t.co/8QMBjaD856,11.522537,http://twitter.com/CancerDotNet/status/473120605248946177,http://twitter.com/cancerdotnet
06/01/14,http://twitter.com/cathyengmd/status/473121603383857152,cathyengmd,"#ASCO14 Plenary session will include pivotal #prostate #cancer trial as well as results of CALGB/@SWOG 80405 for met #crcsm, #endcancer",11.572859,http://twitter.com/CathyEngMD/status/473121603383857152,http://twitter.com/cathyengmd
06/01/14,http://twitter.com/mounabougrini/status/473122509160996864,mounabougrini,"RT @ASCO: Plenary press brief #ASCO14: Bevacizumab + chemo and cetuximab + chemo were equally effective, no meaningful diff. in survival. #…",6.8218465,http://twitter.com/MounaBougrini/status/473122509160996864,http://twitter.com/mounabougrini
06/01/14,http://twitter.com/zizo_mb/status/473124333028929537,zizo_mb,"RT @ASCO: Plenary press brief #ASCO14: Bevacizumab + chemo and cetuximab + chemo were equally effective, no meaningful diff. in survival. #…",6.8218465,http://twitter.com/zizo_mb/status/473124333028929537,http://twitter.com/zizo_mb
06/01/14,http://twitter.com/shewithlynch/status/473124807303655425,shewithlynch,RT @CancerDotNet: Podcast: @ASCO President Dr. Clifford Hudis @CliffordHudis on today's #ASCO14 research #brsm #crcsm #pcsm http://t.co/8QM…,6.652099,http://twitter.com/ShewithLynch/status/473124807303655425,http://twitter.com/shewithlynch
06/01/14,http://twitter.com/shewithlynch/status/473124989164457984,shewithlynch,RT @FightCRC: Research trends toward gene expression profiles of different sub types of CRC- what we're hearing at #ASCO14 #crcsm,7.0640936,http://twitter.com/ShewithLynch/status/473124989164457984,http://twitter.com/shewithlynch
06/01/14,http://twitter.com/anaruizw/status/473125726883811328,anaruizw,"RT @ASCO: Plenary press brief #ASCO14: Bevacizumab + chemo and cetuximab + chemo were equally effective, no meaningful diff. in survival. #…",6.8218465,http://twitter.com/AnaRuizW/status/473125726883811328,http://twitter.com/anaruizw
06/01/14,http://twitter.com/asco/status/473125740540874752,asco,RT @CancerDotNet: Podcast: @ASCO President Dr. Clifford Hudis @CliffordHudis on today's #ASCO14 research #brsm #crcsm #pcsm http://t.co/8QM…,9.9907675,http://twitter.com/ASCO/status/473125740540874752,http://twitter.com/asco
06/01/14,http://twitter.com/fightcrc/status/473127103836078080,fightcrc,"Jeff Allen, ED of Friends of Cancer Research, on Lung Master Protocol &amp; impact on clinical trials #ASCO14 #crcsm http://t.co/G7UFfvRTYH",10.403179,http://twitter.com/FightCRC/status/473127103836078080,http://twitter.com/fightcrc
06/01/14,http://twitter.com/fightcrc/status/473128114563055616,fightcrc,RT @CathyEngMD: #ASCO14 Plenary session will include pivotal #prostate #cancer trial as well as results of CALGB/@SWOG 80405 for met #crcsm…,10.013912,http://twitter.com/FightCRC/status/473128114563055616,http://twitter.com/fightcrc
06/01/14,http://twitter.com/fightcrc/status/473128177393729537,fightcrc,"RT @ASCO: Plenary press brief #ASCO14: Bevacizumab + chemo and cetuximab + chemo were equally effective, no meaningful diff. in survival. #…",10.07411,http://twitter.com/FightCRC/status/473128177393729537,http://twitter.com/fightcrc
06/01/14,http://twitter.com/fightcrc/status/473128197597708288,fightcrc,"RT @SWOG: Good summary 4 patients: CALGB/#SWOGonc 80405 results (bevacizumab, cetuximab both effective w chemo in mCRC) http://t.co/minlzgp…",9.957393,http://twitter.com/FightCRC/status/473128197597708288,http://twitter.com/fightcrc
06/01/14,http://twitter.com/tmasonuhc/status/473128540159098880,tmasonuhc,RT @CancerDotNet: Podcast: @ASCO President Dr. Clifford Hudis @CliffordHudis on today's #ASCO14 research #brsm #crcsm #pcsm http://t.co/8QM…,6.652099,http://twitter.com/tmasonuhc/status/473128540159098880,http://twitter.com/tmasonuhc
06/01/14,http://twitter.com/felis4u4ever/status/473133654093615105,felis4u4ever,RT @FightCRC: Research trends toward gene expression profiles of different sub types of CRC- what we're hearing at #ASCO14 #crcsm,7.0640936,http://twitter.com/Felis4U4ever/status/473133654093615105,http://twitter.com/felis4u4ever
06/01/14,http://twitter.com/felis4u4ever/status/473133745302953984,felis4u4ever,RT @FightCRC: A new consensus group (CRCSC) will help advance a biologic understanding of #coloncancer! #ASCO14 #crcsm,7.086322,http://twitter.com/Felis4U4ever/status/473133745302953984,http://twitter.com/felis4u4ever
06/01/14,http://twitter.com/onced/status/473145148767870976,onced,@scottrberry will be tweeting on @onced from plenary session today for the prostate and CRC studies  #ASC014 #pcsm #crcsm,8.53162,http://twitter.com/OncEd/status/473145148767870976,http://twitter.com/onced
06/01/14,http://twitter.com/erplimackmd/status/473145761329184769,erplimackmd,RT @CathyEngMD: #ASCO14 Plenary session will include pivotal #prostate #cancer trial as well as results of CALGB/@SWOG 80405 for met #crcsm…,6.7616487,http://twitter.com/ERPlimackMD/status/473145761329184769,http://twitter.com/erplimackmd
06/01/14,http://twitter.com/cancergeek/status/473151772421521408,cancergeek,RT @CathyEngMD: #ASCO14 Plenary session will include pivotal #prostate #cancer trial as well as results of CALGB/@SWOG 80405 for met #crcsm…,6.7616487,http://twitter.com/CancerGeek/status/473151772421521408,http://twitter.com/cancergeek
06/01/14,http://twitter.com/tgeorgemd/status/473153236317528064,tgeorgemd,Long awaited for practice MT @ALLIANCE_org: CALGB/@SWOG 80405 results today Plenary Session http://t.co/E0nfeIPfIq #ASCO14 @NRGonc #crcsm,6.733438,http://twitter.com/TGeorgeMD/status/473153236317528064,http://twitter.com/tgeorgemd
06/01/14,http://twitter.com/j_pennett/status/473153671292022785,j_pennett,"RT @ASCO: #ASCO14 plenary briefing features advances in breast, prostate, colorectal cancer treatment http://t.co/azAXaByfaJ #bcsm #pcsm #c…",6.920505,http://twitter.com/j_pennett/status/473153671292022785,http://twitter.com/j_pennett
06/01/14,http://twitter.com/josico99/status/473153960455733248,josico99,RT @FightCRC: Research trends toward gene expression profiles of different sub types of CRC- what we're hearing at #ASCO14 #crcsm,7.0640936,http://twitter.com/josico99/status/473153960455733248,http://twitter.com/josico99
06/01/14,http://twitter.com/drallysonocean/status/473166225091334146,drallysonocean,@ShewithLynch @ASCO @CCAlliance @ColonCancerCDA @TheColonClub @GYRIG @MMfightsCRC #ASCO14 looking forward to plenary session and #crcsm data,8.004515,http://twitter.com/drallysonocean/status/473166225091334146,http://twitter.com/drallysonocean
06/01/14,http://twitter.com/shewithlynch/status/473166365059067904,shewithlynch,RT @drallysonocean: @ShewithLynch @ASCO @CCAlliance @ColonCancerCDA @TheColonClub @GYRIG @MMfightsCRC #ASCO14 looking forward to plenary se…,6.539956,http://twitter.com/ShewithLynch/status/473166365059067904,http://twitter.com/shewithlynch
06/01/14,http://twitter.com/kellyviro/status/473168883223105536,kellyviro,"RT @ASCO: #ASCO14 plenary briefing features advances in breast, prostate, colorectal cancer treatment http://t.co/azAXaByfaJ #bcsm #pcsm #c…",6.920505,http://twitter.com/kellyviro/status/473168883223105536,http://twitter.com/kellyviro
06/01/14,http://twitter.com/drallysonocean/status/473173175392817155,drallysonocean,#ASCO14 BEV=CETUX with FOLFOX or FOLFIRI both acceptable and similarly efficacious. @MMfightsCRC #crcsm,8.21209,http://twitter.com/drallysonocean/status/473173175392817155,http://twitter.com/drallysonocean
06/01/14,http://twitter.com/onced/status/473188849041276928,onced,CALGB 80405 Venook Chemo+Bev vs Chemo+Cetux first line mCRC #crcsm #ASCO14,6.939819,http://twitter.com/OncEd/status/473188849041276928,http://twitter.com/onced
06/01/14,http://twitter.com/tgeorgemd/status/473189190596050945,tgeorgemd,Venook: 1st line mCRC chemo+bev or chemo+CMab OS no diff | @ALLIANCE_org: CALGB/@SWOG 80405 http://t.co/E0nfeIPfIq #ASCO14 @NRGonc #crcsm,6.4020543,http://twitter.com/TGeorgeMD/status/473189190596050945,http://twitter.com/tgeorgemd
06/01/14,http://twitter.com/onced/status/473189349149114369,onced,CALGB 80405 KRAS WT codon 12/13 - FOLFIRI or FOLFOX at investigator's discretion #crcsm #ASCO14,6.554629,http://twitter.com/OncEd/status/473189349149114369,http://twitter.com/onced
06/01/14,http://twitter.com/cancerdotnet/status/473189792227008512,cancerdotnet,Ongoing study indicates 2 targeted therapies equally effctve for met colorectal cancer #ASCO14 summary: #crcsm http://t.co/I4ekDOK3If,11.639377,http://twitter.com/CancerDotNet/status/473189792227008512,http://twitter.com/cancerdotnet
06/01/14,http://twitter.com/dmooneymd/status/473189816390021120,dmooneymd,Swog 80405: K-ras wt met colorectal cancer: physician choice folfiri or folfox...then randomized to cetuximab or bevacizumab. #ASCO14 #crcsm,7.431032,http://twitter.com/dmooneymd/status/473189816390021120,http://twitter.com/dmooneymd
06/01/14,http://twitter.com/onced/status/473190400669536257,onced,"CALGB 80405 N=1137 FOLFIRI 27%, mFOLFOX6 73% primary endpt OS #crcsm #ASCO14",6.6039615,http://twitter.com/OncEd/status/473190400669536257,http://twitter.com/onced
06/01/14,http://twitter.com/andygaya/status/473190462460030976,andygaya,SWOG 80405: K-ras wt met colorectal cancer: physician choice FOLFIRI or FOLFOX then randomized to cetuximab or bevacizumab. #ASCO14 #crcsm,6.526196,http://twitter.com/andygaya/status/473190462460030976,http://twitter.com/andygaya
06/01/14,http://twitter.com/aakonc/status/473190703431155712,aakonc,Median age in c80405 only 59! Remember that when interpreting high OS #crcsm #ASCO14,7.31764,http://twitter.com/aakonc/status/473190703431155712,http://twitter.com/aakonc
06/01/14,http://twitter.com/onced/status/473190821458898945,onced,CALGB 80405 PFS (by investigator): chemo/BV v. chemo/CET: 10.84  v. 10.45 mos.  #crcsm #ASCO14,7.813372,http://twitter.com/OncEd/status/473190821458898945,http://twitter.com/onced
06/01/14,http://twitter.com/andygaya/status/473190982733664256,andygaya,CALGB 80405 OS - chemo/BEv v. chemo/Cetux = 29  v. 29.9 mos; HR = 0.92 (p=0.34).  #crcsm #ASCO14,6.572988,http://twitter.com/andygaya/status/473190982733664256,http://twitter.com/andygaya
06/01/14,http://twitter.com/onced/status/473191643060142081,onced,"CALGB 80405 FOLFOX subset 30 mos (cetux)  vs 27 mos (bev) p-0.09, FOLFIRI arms no difference #crcsm #ASCO14",7.9088573,http://twitter.com/OncEd/status/473191643060142081,http://twitter.com/onced
06/01/14,http://twitter.com/aakonc/status/473191692309626880,aakonc,11% disease free is awesome in met dz#crcsm #asco2014,8.233879,http://twitter.com/aakonc/status/473191692309626880,http://twitter.com/aakonc
06/01/14,http://twitter.com/andygaya/status/473191804716597248,andygaya,"RT @OncEd: CALGB 80405 FOLFOX subset 30 mos (cetux)  vs 27 mos (bev) p-0.09, FOLFIRI arms no difference #crcsm #ASCO14",6.408647,http://twitter.com/andygaya/status/473191804716597248,http://twitter.com/andygaya
06/01/14,http://twitter.com/mmfightscrc/status/473191823251636224,mmfightscrc,RT @drallysonocean: #ASCO14 BEV=CETUX with FOLFOX or FOLFIRI both acceptable and similarly efficacious. @MMfightsCRC #crcsm,6.732894,http://twitter.com/MMfightsCRC/status/473191823251636224,http://twitter.com/mmfightscrc
06/01/14,http://twitter.com/mmfightscrc/status/473191980881969152,mmfightscrc,RT @drallysonocean: @ShewithLynch @ASCO @CCAlliance @ColonCancerCDA @TheColonClub @GYRIG @MMfightsCRC #ASCO14 looking forward to plenary se…,6.539956,http://twitter.com/MMfightsCRC/status/473191980881969152,http://twitter.com/mmfightscrc
06/01/14,http://twitter.com/lucasvsmd/status/473192090386432000,lucasvsmd,RT @aakonc: 11% disease free is awesome in met dz#crcsm #asco2014,7.236328,http://twitter.com/lucasvsmd/status/473192090386432000,http://twitter.com/lucasvsmd
06/01/14,http://twitter.com/onced/status/473192102927798272,onced,CALGB 80405 data on extended Ras and subsequent therapies pending #crcsm #ASCO14,7.223999,http://twitter.com/OncEd/status/473192102927798272,http://twitter.com/onced
06/01/14,http://twitter.com/psumarydom/status/473192252509265920,psumarydom,RT @drallysonocean: #ASCO14 BEV=CETUX with FOLFOX or FOLFIRI both acceptable and similarly efficacious. @MMfightsCRC #crcsm,6.732894,http://twitter.com/PSUMaryDom/status/473192252509265920,http://twitter.com/psumarydom
06/01/14,http://twitter.com/asco/status/473192282980900864,asco,RT @CancerDotNet: Ongoing study indicates 2 targeted therapies equally effctve for met colorectal cancer #ASCO14 summary: #crcsm http://t.c…,10.319388,http://twitter.com/ASCO/status/473192282980900864,http://twitter.com/asco
06/01/14,http://twitter.com/aakonc/status/473192476900360193,aakonc,Results inconclusive until extended ras analysis available IMO #crcsm #ASCO14,7.588233,http://twitter.com/aakonc/status/473192476900360193,http://twitter.com/aakonc
06/01/14,http://twitter.com/coffeydc/status/473193024923922433,coffeydc,"RT @SWOG: Good summary 4 patients: CALGB/#SWOGonc 80405 results (bevacizumab, cetuximab both effective w chemo in mCRC) http://t.co/minlzgp…",6.7051287,http://twitter.com/coffeydc/status/473193024923922433,http://twitter.com/coffeydc
06/01/14,http://twitter.com/oncology23/status/473193794184421376,oncology23,"RT @OncEd: CALGB 80405 FOLFOX subset 30 mos (cetux)  vs 27 mos (bev) p-0.09, FOLFIRI arms no difference #crcsm #ASCO14",6.408647,http://twitter.com/oncology23/status/473193794184421376,http://twitter.com/oncology23
06/01/14,http://twitter.com/fischmd/status/473193944608940032,fischmd,"New benchmarks for 1st line treatment of met #colorectal cancer: &gt;29 month median survival, about 10% live 5 or more years, #ASCO14 #crcsm",13.056308,http://twitter.com/fischmd/status/473193944608940032,http://twitter.com/fischmd
06/01/14,http://twitter.com/asco/status/473194001634705408,asco,"RT @fischmd: New benchmarks for 1st line treatment of met #colorectal cancer: &gt;29 month median survival, about 10% live 5 or more years, #A…",10.201252,http://twitter.com/ASCO/status/473194001634705408,http://twitter.com/asco
06/01/14,http://twitter.com/benparsbenjamin/status/473194048032083970,benparsbenjamin,"RT @fischmd: New benchmarks for 1st line treatment of met #colorectal cancer: &gt;29 month median survival, about 10% live 5 or more years, #A…",6.862584,http://twitter.com/BenparsBenjamin/status/473194048032083970,http://twitter.com/benparsbenjamin
06/01/14,http://twitter.com/lucasvsmd/status/473194295290122243,lucasvsmd,"RT @fischmd: New benchmarks for 1st line treatment of met #colorectal cancer: &gt;29 month median survival, about 10% live 5 or more years, #A…",6.862584,http://twitter.com/lucasvsmd/status/473194295290122243,http://twitter.com/lucasvsmd
06/01/14,http://twitter.com/tony_calles/status/473194312160010240,tony_calles,"RT @fischmd: New benchmarks for 1st line treatment of met #colorectal cancer: &gt;29 month median survival, about 10% live 5 or more years, #A…",6.862584,http://twitter.com/Tony_Calles/status/473194312160010240,http://twitter.com/tony_calles
06/01/14,http://twitter.com/drhedrick/status/473194419449896961,drhedrick,"RT @fischmd: New benchmarks for 1st line treatment of met #colorectal cancer: &gt;29 month median survival, about 10% live 5 or more years, #A…",6.862584,http://twitter.com/DrHedrick/status/473194419449896961,http://twitter.com/drhedrick
06/01/14,http://twitter.com/dmooneymd/status/473195091520024577,dmooneymd,"A ""negative study"" that shows how far we have come in #crcsm extending overall survival to median of 29 mos! #ASCO14 http://t.co/9zkJp2h8W9",7.383656,http://twitter.com/dmooneymd/status/473195091520024577,http://twitter.com/dmooneymd
06/01/14,http://twitter.com/yzafar/status/473195726420574208,yzafar,CALGB 80405: Why do we see a 29mo OS in this study? #ASCO14 #crcsm http://t.co/IiYUF2tSd2,9.00728,http://twitter.com/yzafar/status/473195726420574208,http://twitter.com/yzafar
06/01/14,http://twitter.com/aakonc/status/473196079866204160,aakonc,Yes yes yes yes extended ras could change results c80405#ASCO14 #crcsm,9.016022,http://twitter.com/aakonc/status/473196079866204160,http://twitter.com/aakonc
06/01/14,http://twitter.com/lucasvsmd/status/473196416244801536,lucasvsmd,RT @aakonc: Yes yes yes yes extended ras could change results c80405#ASCO14 #crcsm,7.2489247,http://twitter.com/lucasvsmd/status/473196416244801536,http://twitter.com/lucasvsmd
06/01/14,http://twitter.com/gellyfish5/status/473196706973351937,gellyfish5,RT @CancerDotNet: Ongoing study indicates 2 targeted therapies equally effctve for met colorectal cancer #ASCO14 summary: #crcsm http://t.c…,6.9807205,http://twitter.com/gellyfish5/status/473196706973351937,http://twitter.com/gellyfish5
06/01/14,http://twitter.com/sayrizvi/status/473197421087178752,sayrizvi,“@mtmdphd: MT @alantanmd: No difference OS and PFS in 1st line mCRC bevacizumab vs cetuximab #ASCO14 http://t.co/Vub6PLX55D #crcsm”,6.9721336,http://twitter.com/sayrizvi/status/473197421087178752,http://twitter.com/sayrizvi
06/01/14,http://twitter.com/benparsbenjamin/status/473197424765595649,benparsbenjamin,RT @yzafar: CALGB 80405: Why do we see a 29mo OS in this study? #ASCO14 #crcsm http://t.co/IiYUF2tSd2,6.917134,http://twitter.com/BenparsBenjamin/status/473197424765595649,http://twitter.com/benparsbenjamin
06/01/14,http://twitter.com/drglenweiss/status/473203196585074688,drglenweiss,MT @fischmd: New benchmarks for 1st line treatment of met #colorectal cancer: &gt;29 month median surv #ASCO14 #crcsm progress over hx 9month!,6.8736887,http://twitter.com/DrGlenWeiss/status/473203196585074688,http://twitter.com/drglenweiss
06/02/14,http://twitter.com/kanghoko/status/473310788443058177,kanghoko,RT @dmooneymd: Swog 80405: K-ras wt met colorectal cancer: physician choice folfiri or folfox...then randomized to cetuximab or bevacizumab…,6.3847814,http://twitter.com/KanghoKo/status/473310788443058177,http://twitter.com/kanghoko
06/02/14,http://twitter.com/medicalfacts/status/473372916982505472,medicalfacts,"@PTKevinGrogan fyi Bevacizumab + chemo and cetuximab + chemo were equally effective, no meaningful diff. in survival. #crcsm”",10.404349,http://twitter.com/Medicalfacts/status/473372916982505472,http://twitter.com/medicalfacts
06/02/14,http://twitter.com/wehi_research/status/473406031041531905,wehi_research,A blood test to measure risk of #bowelcancer recurring - Dr Jeanne Tie is speaking at #ASCO14 tumour biology poster highlights today #crcsm,10.054518,http://twitter.com/WEHI_research/status/473406031041531905,http://twitter.com/wehi_research
06/02/14,http://twitter.com/onced/status/473450859305910272,onced,Rodel AIO-04 German Rectal Cancer Study Group 1200 pt adjuvant trial FOLFOX vs 5FU rectal cancer  #crcsm #ASCO14,6.6757913,http://twitter.com/OncEd/status/473450859305910272,http://twitter.com/onced
06/02/14,http://twitter.com/subatomicdoc/status/473450964301905920,subatomicdoc,"Great group, go visit! MT @chris4cure: The CHRIS4LIFE booth at #ASCO14   http://t.co/1AUdejEKbd  via @COLONTOWN / #crcsm",11.127663,http://twitter.com/subatomicdoc/status/473450964301905920,http://twitter.com/subatomicdoc
06/02/14,http://twitter.com/onced/status/473452036034674689,onced,Rodel AIO-04 Oxaliplatin improved 3 yr DFS from 71.2 to 75.9 % HR=0.79 p=0.03  #crcsm #ASCO14,6.545223,http://twitter.com/OncEd/status/473452036034674689,http://twitter.com/onced
06/02/14,http://twitter.com/onced/status/473452363886637056,onced,Rodel AIO-04 Longterm grade 3/4 neuropathy 5%   #crcsm #ASCO14,6.9339,http://twitter.com/OncEd/status/473452363886637056,http://twitter.com/onced
06/02/14,http://twitter.com/onced/status/473453225098891264,onced,Schmoll PETACC6 Adjuvant CapeOx vs Capecitabine - Oxali added to pre and post op tx for rectal cancer #crcsm #ASCO14,6.620644,http://twitter.com/OncEd/status/473453225098891264,http://twitter.com/onced
06/02/14,http://twitter.com/onced/status/473453433094430720,onced,Schmoll PETACC6 1094 patients randomized #crcsm #ASCO14,7.2913203,http://twitter.com/OncEd/status/473453433094430720,http://twitter.com/onced
06/02/14,http://twitter.com/onced/status/473454901750939649,onced,Schmoll PETACC6 3 yr DFS same in CapeOx and Cape arms HR 1.04 #crcsm #ASCO14,7.0946646,http://twitter.com/OncEd/status/473454901750939649,http://twitter.com/onced
06/02/14,http://twitter.com/onced/status/473455304286666752,onced,Schmoll PETACC6 no differences seen in Stage 2 or 3 subgroups #crcsm #ASCO14,7.3180246,http://twitter.com/OncEd/status/473455304286666752,http://twitter.com/onced
06/02/14,http://twitter.com/rad_nation/status/473456751925530624,rad_nation,Preoperative chemoRT &amp; postop 5-FUoxali vs 5-FU in locally advanced #rectalcancer http://t.co/1UD4N2J0W0 #ASCO14 #crcsm #hcsm #radonc,7.384684,http://twitter.com/Rad_Nation/status/473456751925530624,http://twitter.com/rad_nation
06/02/14,http://twitter.com/subatomicdoc/status/473456775354908672,subatomicdoc,Preoperative chemoRT &amp; postop 5-FUoxali vs 5-FU in locally advanced #rectalcancer http://t.co/HiQ1fREfo7 #ASCO14 #crcsm #hcsm #radonc,9.689371,http://twitter.com/subatomicdoc/status/473456775354908672,http://twitter.com/subatomicdoc
06/02/14,http://twitter.com/onced/status/473457599820886016,onced,Schmoll PETACC6 2 more years follow up needed for final evaluation  #crcsm #ASCO14,7.3743534,http://twitter.com/OncEd/status/473457599820886016,http://twitter.com/onced
06/02/14,http://twitter.com/aakonc/status/473459239143604224,aakonc,Interesting conflicting data in rectal ca #ASCO14 #crcsm,7.7964835,http://twitter.com/aakonc/status/473459239143604224,http://twitter.com/aakonc
06/02/14,http://twitter.com/aakonc/status/473459545805561856,aakonc,ADORE establishes postoperative benefit of folfox over 5fu very clearly #crcsm #ASCO14,7.0662036,http://twitter.com/aakonc/status/473459545805561856,http://twitter.com/aakonc
06/02/14,http://twitter.com/onced/status/473464536872534016,onced,ADORE Trial  320 patient trial of Adjuvant FOLFOX vs 5FU  for resected rectal ca after preop chemorads #crcsm #ASCO14,6.664925,http://twitter.com/OncEd/status/473464536872534016,http://twitter.com/onced
06/02/14,http://twitter.com/onced/status/473464859800375297,onced,ADORE trial addition of Oxaliplatin to 5fu  for adjuvant tx of rectal cancer improved 3yr DFS: 72 vs 63% HR=0.63  #crcsm #ASCO14,11.122586,http://twitter.com/OncEd/status/473464859800375297,http://twitter.com/onced
06/02/14,http://twitter.com/onced/status/473465264978538496,onced,"Allegra imbalances in arms in dropout rates, intended tx rates and cape dose may explain lack of benefit seen in PETACC 6  #crcsm #ASCO14",7.02604,http://twitter.com/OncEd/status/473465264978538496,http://twitter.com/onced
06/02/14,http://twitter.com/shewithlynch/status/473465301523128322,shewithlynch,RT @OncEd: ADORE trial addition of Oxaliplatin to 5fu  for adjuvant tx of rectal cancer improved 3yr DFS: 72 vs 63% HR=0.63  #crcsm #ASCO14,6.4020543,http://twitter.com/ShewithLynch/status/473465301523128322,http://twitter.com/shewithlynch
06/02/14,http://twitter.com/shewithlynch/status/473465480749936641,shewithlynch,"RT @subatomicdoc: Great group, go visit! MT @chris4cure: The CHRIS4LIFE booth at #ASCO14   http://t.co/1AUdejEKbd  via @COLONTOWN / #crcsm",7.0334854,http://twitter.com/ShewithLynch/status/473465480749936641,http://twitter.com/shewithlynch
06/02/14,http://twitter.com/onced/status/473465661998792704,onced,Arnold AIO 0207 Non-Inferiority trial of post induction maintenance:  FP+bev vs bev vs no treatment #crcsm #ASCO14,6.9537907,http://twitter.com/OncEd/status/473465661998792704,http://twitter.com/onced
06/02/14,http://twitter.com/onced/status/473465824905560064,onced,Arnold AIO 0207 primary endpoint Time to failure of strategy #crcsm #ASCO14,7.37067,http://twitter.com/OncEd/status/473465824905560064,http://twitter.com/onced
06/02/14,http://twitter.com/onced/status/473466551417712640,onced,Arnold AIO 0207 Cannot conclude that no treatment arm non-inferior for TFS  #crcsm #ASCO14,7.056693,http://twitter.com/OncEd/status/473466551417712640,http://twitter.com/onced
06/02/14,http://twitter.com/aakonc/status/473466682036342785,aakonc,"AIO 207 metCRC randomized to maintenance w 5fu, Bev or no Rx - some tx better than none (non inf analysis)#ASCO14 #crcsm",6.8095555,http://twitter.com/aakonc/status/473466682036342785,http://twitter.com/aakonc
06/02/14,http://twitter.com/mdandersonnews/status/473466980801191936,mdandersonnews,Colon #cancer patients respond to new combination therapy: http://t.co/SvYfKfrHGA #colorectal #crcsm #endcancer,13.292448,http://twitter.com/MDAndersonNews/status/473466980801191936,http://twitter.com/mdandersonnews
06/02/14,http://twitter.com/twittmanda/status/473467249672482816,twittmanda,RT @MDAndersonNews: Colon #cancer patients respond to new combination therapy: http://t.co/SvYfKfrHGA #colorectal #crcsm #endcancer,7.327151,http://twitter.com/twittmanda/status/473467249672482816,http://twitter.com/twittmanda
06/02/14,http://twitter.com/onced/status/473467591181488128,onced,Arnold AIO 0207 interim analysis of OS: 3 arms the same  #crcsm #ASCO14,7.522339,http://twitter.com/OncEd/status/473467591181488128,http://twitter.com/onced
06/02/14,http://twitter.com/ninablue2010/status/473468317303599105,ninablue2010,RT @MDAndersonNews: Colon #cancer patients respond to new combination therapy: http://t.co/SvYfKfrHGA #colorectal #crcsm #endcancer,7.327151,http://twitter.com/NinaBlue2010/status/473468317303599105,http://twitter.com/ninablue2010
06/02/14,http://twitter.com/erv_uth/status/473469220999528448,erv_uth,RT @MDAndersonNews: Colon #cancer patients respond to new combination therapy: http://t.co/SvYfKfrHGA #colorectal #crcsm #endcancer,7.327151,http://twitter.com/ERV_UTH/status/473469220999528448,http://twitter.com/erv_uth
06/02/14,http://twitter.com/tgeorgemd/status/473469360590585856,tgeorgemd,"Dr. Allegra- FOLFOX improves survival in adjuvant rectal cancer, similar to colon. Confirms our clinical practice. #ASCO14 #crcsm @UFHealth",11.567203,http://twitter.com/TGeorgeMD/status/473469360590585856,http://twitter.com/tgeorgemd
06/02/14,http://twitter.com/yzafar/status/473469756943896576,yzafar,"Met colorectal: after 6 cycles of capox-bev, maint cap-bev improves PFS over obs, but no OS benefit. #ASCO14 #crcsm http://t.co/lxiBCcKIf9",9.075894,http://twitter.com/yzafar/status/473469756943896576,http://twitter.com/yzafar
06/02/14,http://twitter.com/drmarkham/status/473469857603022849,drmarkham,MT @tgeorgemd: Dr. Allegra- FOLFOX improves survival in adjuvant rectal cancer. Confirms clinical practice. #ASCO14 #crcsm @UFHealth,10.523045,http://twitter.com/DrMarkham/status/473469857603022849,http://twitter.com/drmarkham
06/02/14,http://twitter.com/onced/status/473470116286722048,onced,Koopman CAIRO3 Maintenace Cape Bev improves time to 2nd progression but not OS compared to no treatment  #crcsm #ASCO14,7.055104,http://twitter.com/OncEd/status/473470116286722048,http://twitter.com/onced
06/02/14,http://twitter.com/radioncbotjp/status/473470169172283394,radioncbotjp,RT @Rad_Nation: Preoperative chemoRT &amp; postop 5-FUoxali vs 5-FU in locally advanced #rectalcancer http://t.co/1UD4N2J0W0 #ASCO14 #crcsm #hc…,6.3647614,http://twitter.com/RadiOncBOTjp/status/473470169172283394,http://twitter.com/radioncbotjp
06/02/14,http://twitter.com/aakonc/status/473470507942047744,aakonc,"RT @yzafar: Met colorectal: after 6 cycles of capox-bev, maint cap-bev improves PFS over obs, but no OS benefit. #ASCO14 #crcsm http://t.co…",6.5326777,http://twitter.com/aakonc/status/473470507942047744,http://twitter.com/aakonc
06/02/14,http://twitter.com/onced/status/473470826898280448,onced,Koopman CAIRO3  QOL : no clinically relevant difference between maintenance and no tx arm  #crcsm #ASCO14,7.2419415,http://twitter.com/OncEd/status/473470826898280448,http://twitter.com/onced
06/02/14,http://twitter.com/drallysonocean/status/473472025583828992,drallysonocean,RT @OncEd: ADORE trial addition of Oxaliplatin to 5fu  for adjuvant tx of rectal cancer improved 3yr DFS: 72 vs 63% HR=0.63  #crcsm #ASCO14,6.4020543,http://twitter.com/drallysonocean/status/473472025583828992,http://twitter.com/drallysonocean
06/02/14,http://twitter.com/tgeorgemd/status/473472264454021120,tgeorgemd,Dr. Saltz: Treatment break strategies for pts w/ mCRC need to be individualized but not abandoned.  Impt for QOL. #ASCO14 #crcsm CAIRO3/AIO,12.165207,http://twitter.com/TGeorgeMD/status/473472264454021120,http://twitter.com/tgeorgemd
06/02/14,http://twitter.com/mtmdphd/status/473472426094108672,mtmdphd,RT @TGeorgeMD: Dr. Saltz: Treatment break strategies for pts w/ mCRC need to be individualized but not abandoned.  Impt for QOL. #ASCO14 #c…,9.895734,http://twitter.com/mtmdphd/status/473472426094108672,http://twitter.com/mtmdphd
06/02/14,http://twitter.com/onced/status/473472698916806657,onced,Saltz Dicsussing AIO 0207 and CAIRO3 induction maintenance studies  #crcsm #ASCO14,7.102886,http://twitter.com/OncEd/status/473472698916806657,http://twitter.com/onced
06/02/14,http://twitter.com/yzafar/status/473473306868592641,yzafar,Saltz: What is the price of stability with bevacizumab? #ASCO14 #crcsm #financialtoxicity http://t.co/fPdqZVU17v,12.873216,http://twitter.com/yzafar/status/473473306868592641,http://twitter.com/yzafar
06/02/14,http://twitter.com/tgeorgemd/status/473473388292616192,tgeorgemd,"Dr. Saltz: single most impt variable in benefit/cost analysis for pts w/ mCRC is not Rx $$, but rather pt TIME. TIME alive. #ASCO14 #crcsm",11.462389,http://twitter.com/TGeorgeMD/status/473473388292616192,http://twitter.com/tgeorgemd
06/02/14,http://twitter.com/emperatrizrios/status/473473430432804864,emperatrizrios,RT @TGeorgeMD: Dr. Saltz: Treatment break strategies for pts w/ mCRC need to be individualized but not abandoned.  Impt for QOL. #ASCO14 #c…,6.708812,http://twitter.com/EmperatrizRios/status/473473430432804864,http://twitter.com/emperatrizrios
06/02/14,http://twitter.com/asco/status/473473704220184576,asco,RT @TGeorgeMD: Dr. Saltz: Treatment break strategies for pts w/ mCRC need to be individualized but not abandoned.  Impt for QOL. #ASCO14 #c…,10.047481,http://twitter.com/ASCO/status/473473704220184576,http://twitter.com/asco
06/02/14,http://twitter.com/asco/status/473473860348948480,asco,RT @yzafar: Saltz: What is the price of stability with bevacizumab? #ASCO14 #crcsm #financialtoxicity http://t.co/fPdqZVU17v,10.234514,http://twitter.com/ASCO/status/473473860348948480,http://twitter.com/asco
06/02/14,http://twitter.com/onced/status/473474194744020992,onced,Saltz treatments need to be individualized but chemo breaks should still be part of treatment of mCRC  #crcsm #ASCO14,7.151837,http://twitter.com/OncEd/status/473474194744020992,http://twitter.com/onced
06/02/14,http://twitter.com/josico99/status/473474372775473153,josico99,"RT @TGeorgeMD: Dr. Allegra- FOLFOX improves survival in adjuvant rectal cancer, similar to colon. Confirms our clinical practice. #ASCO14 #…",6.5190873,http://twitter.com/josico99/status/473474372775473153,http://twitter.com/josico99
06/02/14,http://twitter.com/christinemphmd/status/473476402676006912,christinemphmd,Rt @yzafar: Saltz: What is the price of stability with bevacizumab? #ASCO14 #crcsm #financialtoxicity http://t.co/TX9IUit5T8 #cancervalue,6.8124924,http://twitter.com/christinemphmd/status/473476402676006912,http://twitter.com/christinemphmd
06/02/14,http://twitter.com/drdeborahfisher/status/473476933360320512,drdeborahfisher,"RT @yzafar: Met colorectal: after 6 cycles of capox-bev, maint cap-bev improves PFS over obs, but no OS benefit. #ASCO14 #crcsm http://t.co…",6.5326777,http://twitter.com/DrDeborahFisher/status/473476933360320512,http://twitter.com/drdeborahfisher
06/02/14,http://twitter.com/aakonc/status/473477757662679040,aakonc,OPUS 26% of WT KRAS have other RAS mutations. Should not be treated- save pts toxicity and cost #crcsm #ASCO14,6.906721,http://twitter.com/aakonc/status/473477757662679040,http://twitter.com/aakonc
06/02/14,http://twitter.com/aakonc/status/473479128629645312,aakonc,Opus confirms Extended Ras mutants have worse survival w anti EFGR Overdue mandate ext RAS in all. #ASCO14 #crcsm http://t.co/oDYAgcHapW,7.869507,http://twitter.com/aakonc/status/473479128629645312,http://twitter.com/aakonc
06/02/14,http://twitter.com/dramarivirg/status/473479580096167936,dramarivirg,RT @aakonc: Opus confirms Extended Ras mutants have worse survival w anti EFGR Overdue mandate ext RAS in all. #ASCO14 #crcsm http://t.co/o…,6.854433,http://twitter.com/dramarivirg/status/473479580096167936,http://twitter.com/dramarivirg
06/02/14,http://twitter.com/onced/status/473480840090230784,onced,Tejpar OPUS (FOLFOX +/- Cetuximab for mCRC) update: Extended Ras Analysis  #crcsm #ASCO14,6.872253,http://twitter.com/OncEd/status/473480840090230784,http://twitter.com/onced
06/02/14,http://twitter.com/benparsbenjamin/status/473481324838543360,benparsbenjamin,RT @DrMarkham: MT @tgeorgemd: Dr. Allegra- FOLFOX improves survival in adjuvant rectal cancer. Confirms clinical practice. #ASCO14 #crcsm @…,6.5489073,http://twitter.com/BenparsBenjamin/status/473481324838543360,http://twitter.com/benparsbenjamin
06/02/14,http://twitter.com/ntconnell/status/473484468209324032,ntconnell,"DA Goldstein @WinshipAtEmory Bevacizumab incremental cost-effectiveness ratio $240,195/QALY in metastatic colorectal cancer #ASCO14 #crcsm",6.6433067,http://twitter.com/NTConnell/status/473484468209324032,http://twitter.com/ntconnell
06/02/14,http://twitter.com/cathyengmd/status/473485412657561600,cathyengmd,"#ASCO14:ACCENT database from Sargent indicates regardless of MSI status, stage 3 pts should still receive adjuvant chemo, #endcancer, #crcsm",12.30394,http://twitter.com/CathyEngMD/status/473485412657561600,http://twitter.com/cathyengmd
06/02/14,http://twitter.com/cancerassassin1/status/473485811275792384,cancerassassin1,"RT @CathyEngMD: #ASCO14:ACCENT database from Sargent indicates regardless of MSI status, stage 3 pts should still receive adjuvant chemo, #…",6.881137,http://twitter.com/cancerassassin1/status/473485811275792384,http://twitter.com/cancerassassin1
06/02/14,http://twitter.com/evaglezhaba/status/473488309793353728,evaglezhaba,RT @yzafar: Saltz: What is the price of stability with bevacizumab? #ASCO14 #crcsm #financialtoxicity http://t.co/fPdqZVU17v,6.895846,http://twitter.com/evaglezhaba/status/473488309793353728,http://twitter.com/evaglezhaba
06/02/14,http://twitter.com/onced/status/473489866731585536,onced,Tejpar OPUS Extended Ras Analysis found 26% KRAS/NRAS mutations beyond KRAS exon 2 #crcsm #ASCO14,6.802333,http://twitter.com/OncEd/status/473489866731585536,http://twitter.com/onced
06/02/14,http://twitter.com/fightcrc/status/473490199444750336,fightcrc,New panel genetic tests means those w/ lynch and other crc syndromes 3.5-7% chance test positive for other cancer syndromes. #ASCO14 #crcsm,10.087628,http://twitter.com/FightCRC/status/473490199444750336,http://twitter.com/fightcrc
06/02/14,http://twitter.com/onced/status/473490362938691586,onced,Tejpar OPUS Extended Ras Analysis Ras evaluable population similar to overall pop’n #crcsm #ASCO14,7.121196,http://twitter.com/OncEd/status/473490362938691586,http://twitter.com/onced
06/02/14,http://twitter.com/onced/status/473490542396190720,onced,"Tejpar OPUS Extended Ras Analysis selects population that has improved RR, PFS compared to KRAS WT exon 2 pop’n  #crcsm #ASCO14",8.501154,http://twitter.com/OncEd/status/473490542396190720,http://twitter.com/onced
06/02/14,http://twitter.com/onced/status/473490590370648064,onced,Van Cutsem CRYSTAL Extended Ras Analysis found 15% KRAS/NRAS mutations beyond KRAS exon 2 #crcsm #ASCO14,6.845778,http://twitter.com/OncEd/status/473490590370648064,http://twitter.com/onced
06/02/14,http://twitter.com/onced/status/473490657202700289,onced,Van Cutsem CRYSTAL OS in FOLFIRI cetux 28.4 mos vs 20.2 mos in FOLFIRI alone in extended ras WT group #crcsm #ASCO14,6.6951866,http://twitter.com/OncEd/status/473490657202700289,http://twitter.com/onced
06/02/14,http://twitter.com/onced/status/473490923935244288,onced,"Sargent : for stage 2 patients with dMMR 5 yr OS 90%, no benefit / detriment in OS for 5FU treated patients    #crcsm #ASCO14 #crcsm #ASCO14",7.307367,http://twitter.com/OncEd/status/473490923935244288,http://twitter.com/onced
06/02/14,http://twitter.com/onced/status/473491028474089474,onced,Sargent :  stage 2 patients with dMMR do not need adjutant tx   #crcsm #ASCO14 #crcsm #ASCO14,7.7221713,http://twitter.com/OncEd/status/473491028474089474,http://twitter.com/onced
06/02/14,http://twitter.com/onced/status/473491113815576576,onced,Sargent dMMR does not impact on post recurrence survival #crcsm #ASCO14 #crcsm #ASCO14,7.793357,http://twitter.com/OncEd/status/473491113815576576,http://twitter.com/onced
06/02/14,http://twitter.com/onced/status/473491234213097472,onced,Sargent : data for oxali/irinotecan based regimens maturing  #crcsm #ASCO14,7.0685854,http://twitter.com/OncEd/status/473491234213097472,http://twitter.com/onced
06/02/14,http://twitter.com/onced/status/473491552166113280,onced,Sargent ACCENT database Impact of deficient mismatch repair (dMMR) in Stage 2/3 colon cancer #crcsm #ASCO14,7.223999,http://twitter.com/OncEd/status/473491552166113280,http://twitter.com/onced
06/02/14,http://twitter.com/onced/status/473491758580760576,onced,"Sargent : for stage 2 patients with dMMR 5 yr OS 90%, no benefit / detriment in OS for 5FU treated patients    #crcsm #ASCO14",6.9433784,http://twitter.com/OncEd/status/473491758580760576,http://twitter.com/onced
06/02/14,http://twitter.com/onced/status/473492000466305025,onced,Sargent :  stage 2 patients with dMMR do not need adjutant tx   #crcsm #ASCO14,7.5028887,http://twitter.com/OncEd/status/473492000466305025,http://twitter.com/onced
06/02/14,http://twitter.com/cathyengmd/status/473493997717946368,cathyengmd,"Disagree w/Meropol: ANY rare RAS MT should now result in deferral of antiEGFR rx in mCRC. #crcsm, #endcancer, #ASCO2014.  The data is there!",8.831841,http://twitter.com/CathyEngMD/status/473493997717946368,http://twitter.com/cathyengmd
06/02/14,http://twitter.com/kailesh_rxmkt/status/473498044479332352,kailesh_rxmkt,RT @MDAndersonNews: Colon #cancer patients respond to new combination therapy: http://t.co/SvYfKfrHGA #colorectal #crcsm #endcancer,7.327151,http://twitter.com/Kailesh_RxMKT/status/473498044479332352,http://twitter.com/kailesh_rxmkt
06/02/14,http://twitter.com/glasgowoncology/status/473504301114200064,glasgowoncology,"RT @OncEd: Tejpar OPUS Extended Ras Analysis selects population that has improved RR, PFS compared to KRAS WT exon 2 pop’n  #crcsm #ASCO14",6.7901273,http://twitter.com/GlasgowOncology/status/473504301114200064,http://twitter.com/glasgowoncology
06/02/14,http://twitter.com/dkarikios/status/473504547889885184,dkarikios,RT @yzafar: Saltz: What is the price of stability with bevacizumab? #ASCO14 #crcsm #financialtoxicity http://t.co/fPdqZVU17v,6.895846,http://twitter.com/DKarikios/status/473504547889885184,http://twitter.com/dkarikios
06/02/14,http://twitter.com/coloncanada/status/473513544911441920,coloncanada,RT @OncEd: ADORE trial addition of Oxaliplatin to 5fu  for adjuvant tx of rectal cancer improved 3yr DFS: 72 vs 63% HR=0.63  #crcsm #ASCO14,9.585754,http://twitter.com/coloncanada/status/473513544911441920,http://twitter.com/coloncanada
06/02/14,http://twitter.com/crcareindy/status/473514282249121792,crcareindy,RT @MDAndersonNews: Colon #cancer patients respond to new combination therapy: http://t.co/SvYfKfrHGA #colorectal #crcsm #endcancer,7.327151,http://twitter.com/CrcareINDY/status/473514282249121792,http://twitter.com/crcareindy
06/02/14,http://twitter.com/chrisheery/status/473521741013475328,chrisheery,RT @TGeorgeMD: Dr. Saltz: Treatment break strategies for pts w/ mCRC need to be individualized but not abandoned.  Impt for QOL. #ASCO14 #c…,6.708812,http://twitter.com/ChrisHeery/status/473521741013475328,http://twitter.com/chrisheery
06/02/14,http://twitter.com/dawnka/status/473555729799204865,dawnka,RT @MDAndersonNews: Colon #cancer patients respond to new combination therapy: http://t.co/SvYfKfrHGA #colorectal #crcsm #endcancer,10.547694,http://twitter.com/DawnKA/status/473555729799204865,http://twitter.com/dawnka
06/02/14,http://twitter.com/sreeram08/status/473565081901752321,sreeram08,"RT @yzafar: Met colorectal: after 6 cycles of capox-bev, maint cap-bev improves PFS over obs, but no OS benefit. #ASCO14 #crcsm http://t.co…",6.5326777,http://twitter.com/sreeram08/status/473565081901752321,http://twitter.com/sreeram08
06/02/14,http://twitter.com/cityofhopenews/status/473571555562119168,cityofhopenews,"Plenary #ASCO14 #CancerResearch: #Erbitux, #Avastin found equally effective against #ColorectalCancer http://t.co/b3soSgOqCt #CRCSM",12.197728,http://twitter.com/cityofhopenews/status/473571555562119168,http://twitter.com/cityofhopenews
06/02/14,http://twitter.com/cityofhope/status/473571711036575744,cityofhope,"RT @cityofhopenews: Plenary #ASCO14 #CancerResearch: #Erbitux, #Avastin found equally effective against #ColorectalCancer http://t.co/b3soS…",10.347246,http://twitter.com/cityofhope/status/473571711036575744,http://twitter.com/cityofhope
06/02/14,http://twitter.com/furniturecore/status/473574178495660032,furniturecore,"RT @cityofhopenews: Plenary #ASCO14 #CancerResearch: #Erbitux, #Avastin found equally effective against #ColorectalCancer http://t.co/b3soS…",6.872253,http://twitter.com/furniturecore/status/473574178495660032,http://twitter.com/furniturecore
06/02/14,http://twitter.com/farmaonco/status/473578193480585216,farmaonco,RT @yzafar: Saltz: What is the price of stability with bevacizumab? #ASCO14 #crcsm #financialtoxicity http://t.co/fPdqZVU17v,6.895846,http://twitter.com/FarmaOnco/status/473578193480585216,http://twitter.com/farmaonco
06/02/14,http://twitter.com/paulajgt/status/473585824563752960,paulajgt,RT @yzafar: Saltz: What is the price of stability with bevacizumab? #ASCO14 #crcsm #financialtoxicity http://t.co/fPdqZVU17v,6.895846,http://twitter.com/paulajgt/status/473585824563752960,http://twitter.com/paulajgt
06/02/14,http://twitter.com/oncologyclinics/status/473586057338830848,oncologyclinics,RT @MDAndersonNews: Colon #cancer patients respond to new combination therapy: http://t.co/SvYfKfrHGA #colorectal #crcsm #endcancer,7.327151,http://twitter.com/OncologyClinics/status/473586057338830848,http://twitter.com/oncologyclinics
06/02/14,http://twitter.com/thinkcure/status/473596847278555136,thinkcure,"RT @cityofhopenews: Plenary #ASCO14 #CancerResearch: #Erbitux, #Avastin found equally effective against #ColorectalCancer http://t.co/b3soS…",10.049408,http://twitter.com/ThinkCure/status/473596847278555136,http://twitter.com/thinkcure
06/03/14,http://twitter.com/cathywindels/status/473620052399247362,cathywindels,"RT @TGeorgeMD: Dr. Saltz: single most impt variable in benefit/cost analysis for pts w/ mCRC is not Rx $$, but rather pt TIME. TIME alive. …",6.906721,http://twitter.com/CathyWindels/status/473620052399247362,http://twitter.com/cathywindels
06/03/14,http://twitter.com/drbobgoldberg/status/473653595179872256,drbobgoldberg,"RT @TGeorgeMD: Dr. Saltz: single most impt variable in benefit/cost analysis for pts w/ mCRC is not Rx $$, but rather pt TIME. TIME alive. …",10.132426,http://twitter.com/DrBobGoldberg/status/473653595179872256,http://twitter.com/drbobgoldberg
06/03/14,http://twitter.com/alitimumab/status/473676863261655041,alitimumab,"RT @CathyEngMD: Disagree w/Meropol: ANY rare RAS MT should now result in deferral of antiEGFR rx in mCRC. #crcsm, #endcancer, #ASCO2014.  T…",6.7014003,http://twitter.com/alitimumab/status/473676863261655041,http://twitter.com/alitimumab
06/03/14,http://twitter.com/yzafar/status/473686194287828992,yzafar,"RT @CathyEngMD: Disagree w/Meropol: ANY rare RAS MT should now result in deferral of antiEGFR rx in mCRC. #crcsm, #endcancer, #ASCO2014.  T…",6.7014003,http://twitter.com/yzafar/status/473686194287828992,http://twitter.com/yzafar
06/03/14,http://twitter.com/drhedrick/status/473686741908746240,drhedrick,"RT @CathyEngMD: Disagree w/Meropol: ANY rare RAS MT should now result in deferral of antiEGFR rx in mCRC. #crcsm, #endcancer, #ASCO2014.  T…",6.7014003,http://twitter.com/DrHedrick/status/473686741908746240,http://twitter.com/drhedrick
06/03/14,http://twitter.com/subatomicdoc/status/473761213017767936,subatomicdoc,"@AnjeeDavis @FightCRC @CCAlliance @chris4cure Thank you all for your work to empower, assist my patients and others #ASCO14 #crcsm",11.548059,http://twitter.com/subatomicdoc/status/473761213017767936,http://twitter.com/subatomicdoc
06/03/14,http://twitter.com/fightcrc/status/473762860401950720,fightcrc,"MT Our pleasure! @subatomicdoc // @AnjeeDavis @CCAlliance @chris4cure TY for your work to empower,assist my patients &amp; others #ASCO14 #crcsm",10.111286,http://twitter.com/FightCRC/status/473762860401950720,http://twitter.com/fightcrc
06/03/14,http://twitter.com/abumrap/status/473799400486354944,abumrap,“@OncEd: ADORE trial addition of Oxaliplatin to 5fu  for adjuvant tx of rectal cancer improved 3yr DFS: 72 vs 63% HR=0.63  #crcsm #ASCO14”,7.8677926,http://twitter.com/ABumRap/status/473799400486354944,http://twitter.com/abumrap
06/03/14,http://twitter.com/abumrap/status/473801752530411520,abumrap,"RT @CathyEngMD: Disagree w/Meropol: ANY rare RAS MT should now result in deferral of antiEGFR rx in mCRC. #crcsm, #endcancer, #ASCO2014.  T…",6.7014003,http://twitter.com/ABumRap/status/473801752530411520,http://twitter.com/abumrap
06/03/14,http://twitter.com/abumrap/status/473801839008555008,abumrap,"RT @CathyEngMD: #ASCO14:ACCENT database from Sargent indicates regardless of MSI status, stage 3 pts should still receive adjuvant chemo, #…",6.881137,http://twitter.com/ABumRap/status/473801839008555008,http://twitter.com/abumrap
06/03/14,http://twitter.com/fightcrc/status/473802067308724225,fightcrc,"RT @cityofhopenews: Plenary #ASCO14 #CancerResearch: #Erbitux, #Avastin found equally effective against #ColorectalCancer http://t.co/b3soS…",10.1245165,http://twitter.com/FightCRC/status/473802067308724225,http://twitter.com/fightcrc
06/03/14,http://twitter.com/fightcrc/status/473802248557191168,fightcrc,"RT @CathyEngMD: #ASCO14:ACCENT database from Sargent indicates regardless of MSI status, stage 3 pts should still receive adjuvant chemo, #…",10.133401,http://twitter.com/FightCRC/status/473802248557191168,http://twitter.com/fightcrc
06/03/14,http://twitter.com/fightcrc/status/473802578539843584,fightcrc,"RT @TGeorgeMD: Dr. Allegra- FOLFOX improves survival in adjuvant rectal cancer, similar to colon. Confirms our clinical practice. #ASCO14 #…",9.771351,http://twitter.com/FightCRC/status/473802578539843584,http://twitter.com/fightcrc
06/03/14,http://twitter.com/mtmdphd/status/473841838580064257,mtmdphd,"MT @cancerassassin1: @skopetz: KRas concordance decr to ~65% in Tx;d colorectal #cancer met to lung, brain, peritoneum, bone. #ASCO14 #crcsm",11.039211,http://twitter.com/mtmdphd/status/473841838580064257,http://twitter.com/mtmdphd
06/03/14,http://twitter.com/twittmanda/status/473842348020224000,twittmanda,"RT @mtmdphd: MT @cancerassassin1: @skopetz: KRas concordance decr to ~65% in Tx;d colorectal #cancer met to lung, brain, peritoneum, bone. …",6.6039615,http://twitter.com/twittmanda/status/473842348020224000,http://twitter.com/twittmanda
06/03/14,http://twitter.com/docbkw/status/473851245472780288,docbkw,"RT @mtmdphd: MT @cancerassassin1: @skopetz: KRas concordance decr to ~65% in Tx;d colorectal #cancer met to lung, brain, peritoneum, bone. …",6.6039615,http://twitter.com/Docbkw/status/473851245472780288,http://twitter.com/docbkw
06/03/14,http://twitter.com/cathyengmd/status/473858782943272960,cathyengmd,"#ASCO2014, abs3509. Our interesting results from mdacc on #mCRC looking at MT discordance btwn primary vs met site, #endcancer, #crcsm",6.8124924,http://twitter.com/CathyEngMD/status/473858782943272960,http://twitter.com/cathyengmd
06/03/14,http://twitter.com/drcbsteer/status/473894690073608192,drcbsteer,#ASCO14 #thingsIhavelearned  #crcsm Oxaliplatin should be considered in adjuvant therapy for high risk rectal cancer,8.73522,http://twitter.com/drcbsteer/status/473894690073608192,http://twitter.com/drcbsteer
06/03/14,http://twitter.com/gazulides/status/473898153951780864,gazulides,RT @drcbsteer: #ASCO14 #thingsIhavelearned  #crcsm Oxaliplatin should be considered in adjuvant therapy for high risk rectal cancer,6.947688,http://twitter.com/Gazulides/status/473898153951780864,http://twitter.com/gazulides
06/03/14,http://twitter.com/asco/status/473922772243329024,asco,Understanding colorectal #cancer survivors' needs &amp; preferences for #survivorship info http://t.co/JXUjMBPX8b #crcsm #JOP,12.596487,http://twitter.com/ASCO/status/473922772243329024,http://twitter.com/asco
06/03/14,http://twitter.com/cancerviver/status/473923295356530688,cancerviver,RT @ASCO: Understanding colorectal #cancer survivors' needs &amp; preferences for #survivorship info http://t.co/iW5agH5iZL #crcsm #JOP,7.1097226,http://twitter.com/CANcerviver/status/473923295356530688,http://twitter.com/cancerviver
06/03/14,http://twitter.com/cancernetwrk/status/473924005414830080,cancernetwrk,RT @ASCO: Understanding colorectal #cancer survivors' needs &amp; preferences for #survivorship info http://t.co/JXUjMBPX8b #crcsm #JOP,10.244552,http://twitter.com/CancerNetwrk/status/473924005414830080,http://twitter.com/cancernetwrk
06/03/14,http://twitter.com/sanguinebio/status/473926250332180480,sanguinebio,RT @ASCO: Understanding colorectal #cancer survivors' needs &amp; preferences for #survivorship info http://t.co/JXUjMBPX8b #crcsm #JOP,7.0685854,http://twitter.com/sanguinebio/status/473926250332180480,http://twitter.com/sanguinebio
06/03/14,http://twitter.com/libertyirb/status/473926281583923201,libertyirb,RT @ASCO: Understanding colorectal #cancer survivors' needs &amp; preferences for #survivorship info http://t.co/JXUjMBPX8b #crcsm #JOP,7.0685854,http://twitter.com/LibertyIRB/status/473926281583923201,http://twitter.com/libertyirb
06/03/14,http://twitter.com/lesleylesleys/status/473936708375805952,lesleylesleys,RT @ASCO: Understanding colorectal #cancer survivors' needs &amp; preferences for #survivorship info http://t.co/JXUjMBPX8b #crcsm #JOP,7.0685854,http://twitter.com/LesleyLesleys/status/473936708375805952,http://twitter.com/lesleylesleys
06/03/14,http://twitter.com/wsliauw/status/473938562530807808,wsliauw,RT @drcbsteer: #ASCO14 #thingsIhavelearned  #crcsm Oxaliplatin should be considered in adjuvant therapy for high risk rectal cancer,6.947688,http://twitter.com/wsliauw/status/473938562530807808,http://twitter.com/wsliauw
06/03/14,http://twitter.com/wjta_book/status/473951640198713344,wjta_book,RT @ASCO: Understanding colorectal #cancer survivors' needs &amp; preferences for #survivorship info http://t.co/JXUjMBPX8b #crcsm #JOP,7.0685854,http://twitter.com/WJTA_book/status/473951640198713344,http://twitter.com/wjta_book
06/04/14,http://twitter.com/grantwilliamsmd/status/474001290540769282,grantwilliamsmd,RT @ASCO: Understanding colorectal #cancer survivors' needs &amp; preferences for #survivorship info http://t.co/JXUjMBPX8b #crcsm #JOP,7.0685854,http://twitter.com/GrantWilliamsMD/status/474001290540769282,http://twitter.com/grantwilliamsmd
06/04/14,http://twitter.com/oncnursingnews/status/474193195912687618,oncnursingnews,Screening has prevented half a million colorectal cancers via @Yale http://t.co/cwGYII6HXv #crcsm,7.749839,http://twitter.com/OncNursingNews/status/474193195912687618,http://twitter.com/oncnursingnews
06/04/14,http://twitter.com/talkabouthealth/status/474210524150767617,talkabouthealth,"At time of #Coloncancer  screening what questions should patient ask a physician?Dr.Krishnan @emoryhealthcare
http://t.co/EiLe2F7hsw #crcsm",11.95012,http://twitter.com/talkabouthealth/status/474210524150767617,http://twitter.com/talkabouthealth
06/04/14,http://twitter.com/aliveandkickndd/status/474210797712080896,aliveandkickndd,"RT @talkabouthealth: At time of #Coloncancer  screening what questions should patient ask a physician?Dr.Krishnan @emoryhealthcare
http://t…",7.064095,http://twitter.com/AliveAndKicknDD/status/474210797712080896,http://twitter.com/aliveandkickndd
06/04/14,http://twitter.com/ascopost/status/474245766295613442,ascopost,Chemo + 1st-Line Bevacizumab or Cetuximab Offer Similar Survival in Metastatic Colorectal Cancer http://t.co/4HkzTdfHbE #ASCO14 #crcsm,11.71186,http://twitter.com/ASCOPost/status/474245766295613442,http://twitter.com/ascopost
06/04/14,http://twitter.com/gmailhalcon/status/474247536568717312,gmailhalcon,RT @ASCOPost: Chemo + 1st-Line Bevacizumab or Cetuximab Offer Similar Survival in Metastatic Colorectal Cancer http://t.co/4HkzTdfHbE #ASCO…,6.754571,http://twitter.com/GmailHalcon/status/474247536568717312,http://twitter.com/gmailhalcon
06/04/14,http://twitter.com/cce80111/status/474248086881972225,cce80111,RT @ASCOPost: Chemo + 1st-Line Bevacizumab or Cetuximab Offer Similar Survival in Metastatic Colorectal Cancer http://t.co/4HkzTdfHbE #ASCO…,6.754571,http://twitter.com/CCE80111/status/474248086881972225,http://twitter.com/cce80111
06/04/14,http://twitter.com/marioivega/status/474262060420050945,marioivega,RT @ASCOPost: Chemo + 1st-Line Bevacizumab or Cetuximab Offer Similar Survival in Metastatic Colorectal Cancer http://t.co/4HkzTdfHbE #ASCO…,6.754571,http://twitter.com/marioivega/status/474262060420050945,http://twitter.com/marioivega
06/04/14,http://twitter.com/drallysonocean/status/474262933296676864,drallysonocean,"GI ROCKSTAR @FeliceSchnoll @MMfightsCRC with @AliveAndKicknDD CRC Advocate ROCKSTAR @nyphospital at C5 
colon cancer coalition #crcsm",7.7375813,http://twitter.com/drallysonocean/status/474262933296676864,http://twitter.com/drallysonocean
06/04/14,http://twitter.com/aliveandkickndd/status/474289669681991680,aliveandkickndd,"RT @drallysonocean: GI ROCKSTAR @FeliceSchnoll @MMfightsCRC with @AliveAndKicknDD CRC Advocate ROCKSTAR @nyphospital at C5 
colon cancer co…",6.7198267,http://twitter.com/AliveAndKicknDD/status/474289669681991680,http://twitter.com/aliveandkickndd
06/05/14,http://twitter.com/fischmd/status/474360922220552192,fischmd,"Symptom burden among young adults with #breastcancer or #colorectal cancer, @journalcancer http://t.co/ISAvrPdk7P #ayacsm #crcsm #bcsm",12.382499,http://twitter.com/fischmd/status/474360922220552192,http://twitter.com/fischmd
06/05/14,http://twitter.com/drjohnweru/status/474363141384839168,drjohnweru,"RT @fischmd: Symptom burden among young adults with #breastcancer or #colorectal cancer, @journalcancer http://t.co/ISAvrPdk7P #ayacsm #crc…",6.944906,http://twitter.com/DrJohnWeru/status/474363141384839168,http://twitter.com/drjohnweru
06/05/14,http://twitter.com/hayeslat/status/474365192164212736,hayeslat,"RT @fischmd: Symptom burden among young adults with #breastcancer or #colorectal cancer, @journalcancer http://t.co/ISAvrPdk7P #ayacsm #crc…",10.116932,http://twitter.com/hayeslat/status/474365192164212736,http://twitter.com/hayeslat
06/05/14,http://twitter.com/heckelme/status/474366206900981760,heckelme,"RT @fischmd: Symptom burden among young adults with #breastcancer or #colorectal cancer, @journalcancer http://t.co/ISAvrPdk7P #ayacsm #crc…",6.944906,http://twitter.com/heckelme/status/474366206900981760,http://twitter.com/heckelme
06/05/14,http://twitter.com/tt_mdanderson/status/474375516443922434,tt_mdanderson,"RT @fischmd: Symptom burden among young adults with #breastcancer or #colorectal cancer, @journalcancer http://t.co/ISAvrPdk7P #ayacsm #crc…",6.944906,http://twitter.com/TT_MDAnderson/status/474375516443922434,http://twitter.com/tt_mdanderson
06/05/14,http://twitter.com/profmmelendez/status/474392765401661440,profmmelendez,RT @ASCOPost: Chemo + 1st-Line Bevacizumab or Cetuximab Offer Similar Survival in Metastatic Colorectal Cancer http://t.co/4HkzTdfHbE #ASCO…,6.754571,http://twitter.com/profmmelendez/status/474392765401661440,http://twitter.com/profmmelendez
06/05/14,http://twitter.com/ek_drake/status/474417717496131584,ek_drake,"RT @fischmd: Symptom burden among young adults with #breastcancer or #colorectal cancer, @journalcancer http://t.co/ISAvrPdk7P #ayacsm #crc…",6.944906,http://twitter.com/EK_Drake/status/474417717496131584,http://twitter.com/ek_drake
06/05/14,http://twitter.com/woodbd/status/474499060645113856,woodbd,"RT @fischmd: Symptom burden among young adults with #breastcancer or #colorectal cancer, @journalcancer http://t.co/ISAvrPdk7P #ayacsm #crc…",6.944906,http://twitter.com/WoodBD/status/474499060645113856,http://twitter.com/woodbd
06/05/14,http://twitter.com/aakonc/status/474512861075886080,aakonc,"""@AnnalsofIM: How old is too old to screen for crc http://t.co/6Sljc40XL8?""cost effective up to 86! #crcsm",7.630606,http://twitter.com/aakonc/status/474512861075886080,http://twitter.com/aakonc
06/05/14,http://twitter.com/k_basenengquist/status/474552531134468097,k_basenengquist,"Fish, #Exercise May Help Thwart #ColonCancer’s Return: Study http://t.co/tADvlQoE78 #CRCSM #endcancer",8.343278,http://twitter.com/K_BasenEngquist/status/474552531134468097,http://twitter.com/k_basenengquist
06/05/14,http://twitter.com/bsauser/status/474553487557009409,bsauser,"RT @K_BasenEngquist: Fish, #Exercise May Help Thwart #ColonCancer’s Return: Study http://t.co/tADvlQoE78 #CRCSM #endcancer",7.2913203,http://twitter.com/bsauser/status/474553487557009409,http://twitter.com/bsauser
06/05/14,http://twitter.com/focusedonhealth/status/474554341312176129,focusedonhealth,"RT @K_BasenEngquist: Fish, #Exercise May Help Thwart #ColonCancer’s Return: Study http://t.co/sOpi56KG0m #CRCSM #endcancer",10.478604,http://twitter.com/focusedonhealth/status/474554341312176129,http://twitter.com/focusedonhealth
06/05/14,http://twitter.com/onacom/status/474577720459145216,onacom,RT @ASCO: Understanding colorectal #cancer survivors' needs &amp; preferences for #survivorship info http://t.co/84It6yTXOw #crcsm #JOP,7.1479,http://twitter.com/ONAcom/status/474577720459145216,http://twitter.com/onacom
06/06/14,http://twitter.com/mphpublichealth/status/474733708914982912,mphpublichealth,RT @ASCO: Understanding colorectal #cancer survivors' needs &amp; preferences for #survivorship info http://t.co/4X3v3waeVe #crcsm #JOP,7.1097226,http://twitter.com/MPHPublicHealth/status/474733708914982912,http://twitter.com/mphpublichealth
06/06/14,http://twitter.com/audvin/status/474837234160771072,audvin,Colon cancer is a silent killer. If you don’t know the enemy you can not beat him. – @LucColemont #doctors20 #coloncancer #crcsm,8.508795,http://twitter.com/audvin/status/474837234160771072,http://twitter.com/audvin
06/06/14,http://twitter.com/nxtstop1/status/474837413550751744,nxtstop1,RT @audvin: Colon cancer is a silent killer. If you don’t know the enemy you can not beat him. – @LucColemont #doctors20 #coloncancer #crcsm,7.0203023,http://twitter.com/nxtstop1/status/474837413550751744,http://twitter.com/nxtstop1
06/06/14,http://twitter.com/swelldiabetes/status/474837633605312513,swelldiabetes,RT @audvin: Colon cancer is a silent killer. If you don’t know the enemy you can not beat him. – @LucColemont #doctors20 #coloncancer #crcsm,7.0203023,http://twitter.com/swelldiabetes/status/474837633605312513,http://twitter.com/swelldiabetes
06/06/14,http://twitter.com/audvin/status/474837655654785024,audvin,Use #crcsm for Colon- and Colorectal Cancer #doctors20 @subatomicdoc @pfanderson,11.554382,http://twitter.com/audvin/status/474837655654785024,http://twitter.com/audvin
06/06/14,http://twitter.com/nxtstop1/status/474837935691272192,nxtstop1,RT @audvin: Use #crcsm for Colon- and Colorectal Cancer #doctors20 @subatomicdoc @pfanderson,7.1374874,http://twitter.com/nxtstop1/status/474837935691272192,http://twitter.com/nxtstop1
06/06/14,http://twitter.com/chimoose/status/474838069599014913,chimoose,The passion of @LucColemont for saving lives from colon cancer is so inspiring #doctors20 #crcsm,12.973678,http://twitter.com/chimoose/status/474838069599014913,http://twitter.com/chimoose
06/06/14,http://twitter.com/nxtstop1/status/474838199924051969,nxtstop1,RT @chimoose: The passion of @LucColemont for saving lives from colon cancer is so inspiring #doctors20 #crcsm,7.36292,http://twitter.com/nxtstop1/status/474838199924051969,http://twitter.com/nxtstop1
06/06/14,http://twitter.com/doctors20/status/474838372650086400,doctors20,RT @chimoose: The passion of @LucColemont for saving lives from colon cancer is so inspiring #doctors20 #crcsm,7.36292,http://twitter.com/doctors20/status/474838372650086400,http://twitter.com/doctors20
06/06/14,http://twitter.com/bart/status/474838700757889024,bart,RT @chimoose: The passion of @LucColemont for saving lives from colon cancer is so inspiring #doctors20 #crcsm,10.905025,http://twitter.com/bart/status/474838700757889024,http://twitter.com/bart
06/06/14,http://twitter.com/chimoose/status/474838944304336896,chimoose,Colon cancer is 95% curable and can be detected with a simple test. #Doctors20 #crcsm,12.812607,http://twitter.com/chimoose/status/474838944304336896,http://twitter.com/chimoose
06/06/14,http://twitter.com/alanroygbiv/status/474839214656614400,alanroygbiv,RT @audvin: Use #crcsm for Colon- and Colorectal Cancer #doctors20 @subatomicdoc @pfanderson,10.317711,http://twitter.com/alanROYGBIV/status/474839214656614400,http://twitter.com/alanroygbiv
06/06/14,http://twitter.com/mariapuigdou/status/474839251344162816,mariapuigdou,RT @chimoose: Colon cancer is 95% curable and can be detected with a simple test. #Doctors20 #crcsm,10.456058,http://twitter.com/mariapuigdou/status/474839251344162816,http://twitter.com/mariapuigdou
06/06/14,http://twitter.com/nxtstop1/status/474839375621025792,nxtstop1,RT @chimoose: Colon cancer is 95% curable and can be detected with a simple test. #Doctors20 #crcsm,7.2873607,http://twitter.com/nxtstop1/status/474839375621025792,http://twitter.com/nxtstop1
06/06/14,http://twitter.com/audvin/status/474839469842255873,audvin,Pen pal with Brad Pitt @LucColemont . Awesome #crcsm social media campaign #doctors20 http://t.co/SUTpdKpxvq,8.314772,http://twitter.com/audvin/status/474839469842255873,http://twitter.com/audvin
06/06/14,http://twitter.com/rteston/status/474839476041441280,rteston,RT @chimoose: The passion of @LucColemont for saving lives from colon cancer is so inspiring #doctors20 #crcsm,10.632716,http://twitter.com/rteston/status/474839476041441280,http://twitter.com/rteston
06/06/14,http://twitter.com/medzineapp/status/474839532744216577,medzineapp,RT @chimoose: Colon cancer is 95% curable and can be detected with a simple test. #Doctors20 #crcsm,7.2873607,http://twitter.com/Medzineapp/status/474839532744216577,http://twitter.com/medzineapp
06/06/14,http://twitter.com/power4patients/status/474839536531685376,power4patients,RT @chimoose: Colon cancer is 95% curable and can be detected with a simple test. #Doctors20 #crcsm,7.2873607,http://twitter.com/power4patients/status/474839536531685376,http://twitter.com/power4patients
06/06/14,http://twitter.com/bbartes/status/474839593360326656,bbartes,RT @chimoose: The passion of @LucColemont for saving lives from colon cancer is so inspiring #doctors20 #crcsm,7.36292,http://twitter.com/BBartes/status/474839593360326656,http://twitter.com/bbartes
06/06/14,http://twitter.com/chimoose/status/474839629867524096,chimoose,I think that @LucColemont missed a career as a PR person - he's got a real knack for getting people's attention. #Doctors20 #crcsm,11.658065,http://twitter.com/chimoose/status/474839629867524096,http://twitter.com/chimoose
06/06/14,http://twitter.com/nxtstop1/status/474839875590451200,nxtstop1,RT @audvin: Pen pal with Brad Pitt @LucColemont . Awesome #crcsm social media campaign #doctors20 http://t.co/SUTpdKpxvq,7.2745795,http://twitter.com/nxtstop1/status/474839875590451200,http://twitter.com/nxtstop1
06/06/14,http://twitter.com/nxtstop1/status/474839924949012482,nxtstop1,RT @chimoose: I think that @LucColemont missed a career as a PR person - he's got a real knack for getting people's attention. #Doctors20 #…,7.0971274,http://twitter.com/nxtstop1/status/474839924949012482,http://twitter.com/nxtstop1
06/06/14,http://twitter.com/gleefulkaz/status/474840612588748800,gleefulkaz,RT @chimoose: I think that @LucColemont missed a career as a PR person - he's got a real knack for getting people's attention. #Doctors20 #…,7.0971274,http://twitter.com/GleefulKaz/status/474840612588748800,http://twitter.com/gleefulkaz
06/06/14,http://twitter.com/iangertler/status/474850492451811328,iangertler,@chimoose re: @LucColemont missed career as a PR person... #Doctors20 #crcsm &gt; Ha ... something to fall back on if medicine gets boring! ;-),10.69368,http://twitter.com/IanGertler/status/474850492451811328,http://twitter.com/iangertler
06/06/14,http://twitter.com/nelson_carreras/status/474859304101871616,nelson_carreras,RT @chimoose: Colon cancer is 95% curable and can be detected with a simple test. #Doctors20 #crcsm,7.2873607,http://twitter.com/Nelson_Carreras/status/474859304101871616,http://twitter.com/nelson_carreras
06/06/14,http://twitter.com/brite_dee/status/474889539971219457,brite_dee,RT @chimoose: Colon cancer is 95% curable and can be detected with a simple test. #Doctors20 #crcsm,7.2873607,http://twitter.com/brite_dee/status/474889539971219457,http://twitter.com/brite_dee
06/06/14,http://twitter.com/cmaer/status/474890552412864512,cmaer,Worth retweeting RT @chimoose: Colon cancer is 95% curable and can be detected with a simple test. #Doctors20 #crcsm @coloncanada,12.290328,http://twitter.com/cmaer/status/474890552412864512,http://twitter.com/cmaer
06/06/14,http://twitter.com/givoly/status/474890972137287680,givoly,RT @cmaer: Worth retweeting RT @chimoose: Colon cancer is 95% curable and can be detected with a simple test. #Doctors20 #crcsm @coloncanada,10.129086,http://twitter.com/givoly/status/474890972137287680,http://twitter.com/givoly
06/06/14,http://twitter.com/paulgrant/status/474891231827595264,paulgrant,RT @cmaer: Worth retweeting RT @chimoose: Colon cancer is 95% curable and can be detected with a simple test. #Doctors20 #crcsm @coloncanada,10.098428,http://twitter.com/paulgrant/status/474891231827595264,http://twitter.com/paulgrant
06/06/14,http://twitter.com/fabriceangelini/status/474891542453567488,fabriceangelini,RT @cmaer: Worth retweeting RT @chimoose: Colon cancer is 95% curable and can be detected with a simple test. #Doctors20 #crcsm @coloncanada,6.9285994,http://twitter.com/FabriceAngelini/status/474891542453567488,http://twitter.com/fabriceangelini
06/06/14,http://twitter.com/denniskendel/status/474891843092484096,denniskendel,RT @cmaer: Worth retweeting RT @chimoose: Colon cancer is 95% curable and can be detected with a simple test. #Doctors20 #crcsm @coloncanada,6.9285994,http://twitter.com/DennisKendel/status/474891843092484096,http://twitter.com/denniskendel
06/06/14,http://twitter.com/drnoelgrisdale/status/474902108932554754,drnoelgrisdale,RT @cmaer: Worth retweeting RT @chimoose: Colon cancer is 95% curable and can be detected with a simple test. #Doctors20 #crcsm @coloncanada,6.9285994,http://twitter.com/DrNoelGrisdale/status/474902108932554754,http://twitter.com/drnoelgrisdale
06/06/14,http://twitter.com/shewithlynch/status/474942915572416512,shewithlynch,"RT @talkabouthealth: At time of #Coloncancer  screening what questions should patient ask a physician?Dr.Krishnan @emoryhealthcare
http://t…",7.064095,http://twitter.com/ShewithLynch/status/474942915572416512,http://twitter.com/shewithlynch
06/06/14,http://twitter.com/drfrankfarrell/status/474954404903129088,drfrankfarrell,"RT @talkabouthealth: At time of #Coloncancer  screening what questions should patient ask a physician?Dr.Krishnan @emoryhealthcare
http://t…",7.064095,http://twitter.com/DrFrankFarrell/status/474954404903129088,http://twitter.com/drfrankfarrell
06/06/14,http://twitter.com/coloncanceruk/status/474977648054390784,coloncanceruk,RT @drcbsteer: #ASCO14 #thingsIhavelearned  #crcsm Oxaliplatin should be considered in adjuvant therapy for high risk rectal cancer,6.947688,http://twitter.com/ColonCancerUK/status/474977648054390784,http://twitter.com/coloncanceruk
06/06/14,http://twitter.com/coloncanceruk/status/474978510340378624,coloncanceruk,"RT @talkabouthealth: Stage 3 #coloncancer,how do you prepare &amp; educate patient  on oxaliplatin &amp; 5-FU? Dr.Kopetz @MDAndersonNews http://t.c…",6.545223,http://twitter.com/ColonCancerUK/status/474978510340378624,http://twitter.com/coloncanceruk
06/06/14,http://twitter.com/sevierhere/status/475059863303647232,sevierhere,RT @MDAndersonNews: Colon #cancer patients respond to new combination therapy: http://t.co/aoMG9YfAP7 #colorectal #crcsm #endcancer,10.706495,http://twitter.com/sevierhere/status/475059863303647232,http://twitter.com/sevierhere
06/07/14,http://twitter.com/drmiguelperales/status/475081121516900352,drmiguelperales,Colon Cancer Screening Saves Lives http://t.co/R2wXPtasIx #crcsm,13.679385,http://twitter.com/DrMiguelPerales/status/475081121516900352,http://twitter.com/drmiguelperales
06/07/14,http://twitter.com/fischmd/status/475092330027171840,fischmd,Aiming for 80% screening rates by 2018: RT @DrMiguelPerales: #ColonCancer Screening Saves Lives http://t.co/z1xrzuS7B8 #crcsm,12.874064,http://twitter.com/fischmd/status/475092330027171840,http://twitter.com/fischmd
06/07/14,http://twitter.com/twittmanda/status/475092785679171586,twittmanda,RT @fischmd: Aiming for 80% screening rates by 2018: RT @DrMiguelPerales: #ColonCancer Screening Saves Lives http://t.co/z1xrzuS7B8 #crcsm,6.9498715,http://twitter.com/twittmanda/status/475092785679171586,http://twitter.com/twittmanda
06/07/14,http://twitter.com/mfmulcahymd/status/475150714944368640,mfmulcahymd,RT @fischmd: Aiming for 80% screening rates by 2018: RT @DrMiguelPerales: #ColonCancer Screening Saves Lives http://t.co/z1xrzuS7B8 #crcsm,6.9498715,http://twitter.com/MFMulcahyMD/status/475150714944368640,http://twitter.com/mfmulcahymd
06/07/14,http://twitter.com/shewithlynch/status/475228541831761920,shewithlynch,RT @fischmd: Aiming for 80% screening rates by 2018: RT @DrMiguelPerales: #ColonCancer Screening Saves Lives http://t.co/z1xrzuS7B8 #crcsm,6.9498715,http://twitter.com/ShewithLynch/status/475228541831761920,http://twitter.com/shewithlynch
06/07/14,http://twitter.com/sloan_kettering/status/475270014875205632,sloan_kettering,RT @DrMiguelPerales: Colon Cancer Screening Saves Lives http://t.co/R2wXPtasIx #crcsm,10.993772,http://twitter.com/sloan_kettering/status/475270014875205632,http://twitter.com/sloan_kettering
06/07/14,http://twitter.com/alipomata/status/475271306729234433,alipomata,RT @DrMiguelPerales: Colon Cancer Screening Saves Lives http://t.co/R2wXPtasIx #crcsm,7.7383924,http://twitter.com/AliPomata/status/475271306729234433,http://twitter.com/alipomata
06/07/14,http://twitter.com/kizzo1/status/475271935933562880,kizzo1,RT @DrMiguelPerales: Colon Cancer Screening Saves Lives http://t.co/R2wXPtasIx #crcsm,7.7383924,http://twitter.com/kizzo1/status/475271935933562880,http://twitter.com/kizzo1
06/07/14,http://twitter.com/amitbhaskar/status/475273205704167425,amitbhaskar,RT @DrMiguelPerales: Colon Cancer Screening Saves Lives http://t.co/R2wXPtasIx #crcsm,7.7383924,http://twitter.com/amitbhaskar/status/475273205704167425,http://twitter.com/amitbhaskar
06/07/14,http://twitter.com/melpalmd/status/475273643195629568,melpalmd,Good News! Increased Uptake of Colon Cancer Screening Over 4 Decades Prevents Half Million Cancers #crcsm http://t.co/wENWPrDzmG,7.5665703,http://twitter.com/MelPalMD/status/475273643195629568,http://twitter.com/melpalmd
06/07/14,http://twitter.com/mdahpbaloia/status/475273973077274624,mdahpbaloia,RT @fischmd: Aiming for 80% screening rates by 2018: RT @DrMiguelPerales: #ColonCancer Screening Saves Lives http://t.co/z1xrzuS7B8 #crcsm,6.9498715,http://twitter.com/mdahpbaloia/status/475273973077274624,http://twitter.com/mdahpbaloia
06/07/14,http://twitter.com/hcaoncnursenav/status/475275504283836417,hcaoncnursenav,RT @DrMiguelPerales: Colon Cancer Screening Saves Lives http://t.co/R2wXPtasIx #crcsm,7.7383924,http://twitter.com/HCAOncNurseNav/status/475275504283836417,http://twitter.com/hcaoncnursenav
06/07/14,http://twitter.com/talkabouthealth/status/475275768415526913,talkabouthealth,RT @fischmd: Aiming for 80% screening rates by 2018: RT @DrMiguelPerales: #ColonCancer Screening Saves Lives http://t.co/z1xrzuS7B8 #crcsm,10.29838,http://twitter.com/talkabouthealth/status/475275768415526913,http://twitter.com/talkabouthealth
06/07/14,http://twitter.com/chapman_melanie/status/475278368212930560,chapman_melanie,RT @fischmd: Aiming for 80% screening rates by 2018: RT @DrMiguelPerales: #ColonCancer Screening Saves Lives http://t.co/z1xrzuS7B8 #crcsm,6.9498715,http://twitter.com/Chapman_Melanie/status/475278368212930560,http://twitter.com/chapman_melanie
06/07/14,http://twitter.com/liber8health/status/475279503858872320,liber8health,RT @DrMiguelPerales: Colon Cancer Screening Saves Lives http://t.co/R2wXPtasIx #crcsm,7.7383924,http://twitter.com/liber8health/status/475279503858872320,http://twitter.com/liber8health
06/07/14,http://twitter.com/medsexual/status/475282057598611458,medsexual,RT @DrMiguelPerales: Colon Cancer Screening Saves Lives http://t.co/R2wXPtasIx #crcsm,7.7383924,http://twitter.com/medsexual/status/475282057598611458,http://twitter.com/medsexual
06/07/14,http://twitter.com/josico99/status/475295093738311682,josico99,RT @DrMiguelPerales: Colon Cancer Screening Saves Lives http://t.co/R2wXPtasIx #crcsm,7.7383924,http://twitter.com/josico99/status/475295093738311682,http://twitter.com/josico99
06/07/14,http://twitter.com/brunomtzleo/status/475305516051095552,brunomtzleo,“@DrMiguelPerales: Colon #Cancer Screening Saves Lives http://t.co/BUzigP0RlQ #crcsm”,7.753398,http://twitter.com/brunomtzleo/status/475305516051095552,http://twitter.com/brunomtzleo
06/07/14,http://twitter.com/luriecancer/status/475386054799654912,luriecancer,"It's ""a big deal"" Study by @jamesbyu @YaleCancer proves #ColorectalCancer Screening Saves Lives http://t.co/q9lQk83WRE @nytimeswell #crcsm",10.242438,http://twitter.com/LurieCancer/status/475386054799654912,http://twitter.com/luriecancer
06/07/14,http://twitter.com/jamesbyu/status/475395854309007360,jamesbyu,"RT @LurieCancer: It's ""a big deal"" Study by @jamesbyu @YaleCancer proves #ColorectalCancer Screening Saves Lives http://t.co/q9lQk83WRE @ny…",7.023806,http://twitter.com/jamesbyu/status/475395854309007360,http://twitter.com/jamesbyu
06/07/14,http://twitter.com/drallysonocean/status/475424218415235072,drallysonocean,@nyppresident @nyphospital Join @feliceschnoll @MMfightsCRC @drallysonocean at @GYRIG 5K race tomorrow AM to end #crcsm #colorectalcancer,11.559396,http://twitter.com/drallysonocean/status/475424218415235072,http://twitter.com/drallysonocean
06/08/14,http://twitter.com/mmfightscrc/status/475432199039512577,mmfightscrc,RT @drallysonocean: @nyppresident @nyphospital Join @feliceschnoll @MMfightsCRC @drallysonocean at @GYRIG 5K race tomorrow AM to end #crcsm…,6.6190777,http://twitter.com/MMfightsCRC/status/475432199039512577,http://twitter.com/mmfightscrc
06/08/14,http://twitter.com/aliveandkickndd/status/475591231582380032,aliveandkickndd,RT @drallysonocean: @nyppresident @nyphospital Join @feliceschnoll @MMfightsCRC @drallysonocean at @GYRIG 5K race tomorrow AM to end #crcsm…,6.6190777,http://twitter.com/AliveAndKicknDD/status/475591231582380032,http://twitter.com/aliveandkickndd
06/08/14,http://twitter.com/doctor_govind/status/475602932810149888,doctor_govind,RT @drallysonocean: @nyppresident @nyphospital Join @feliceschnoll @MMfightsCRC @drallysonocean at @GYRIG 5K race tomorrow AM to end #crcsm…,6.6190777,http://twitter.com/doctor_govind/status/475602932810149888,http://twitter.com/doctor_govind
06/08/14,http://twitter.com/ranjitbindra/status/475640857606242304,ranjitbindra,"RT @LurieCancer: It's ""a big deal"" Study by @jamesbyu @YaleCancer proves #ColorectalCancer Screening Saves Lives http://t.co/q9lQk83WRE @ny…",7.023806,http://twitter.com/ranjitbindra/status/475640857606242304,http://twitter.com/ranjitbindra
06/08/14,http://twitter.com/trzaska/status/475652344445939712,trzaska,RT @drallysonocean: @nyppresident @nyphospital Join @feliceschnoll @MMfightsCRC @drallysonocean at @GYRIG 5K race tomorrow AM to end #crcsm…,9.790992,http://twitter.com/Trzaska/status/475652344445939712,http://twitter.com/trzaska
06/09/14,http://twitter.com/granitehead/status/475975367787028481,granitehead,"MT ""Does It Matter Who Is the Doctor Who Performs Your Screening Colonoscopy? by @ElaineSchattner - http://t.co/dry2SCBRX9 ” #crcsm",7.1639013,http://twitter.com/granitehead/status/475975367787028481,http://twitter.com/granitehead
06/09/14,http://twitter.com/mtmdphd/status/476084035174019072,mtmdphd,Does It Matter Who Is the Doctor Who Performs Your Screening Colonoscopy? - via @ElaineSchattner @Forbes http://t.co/fbvdCgsuE6 #crcsm,11.8358,http://twitter.com/mtmdphd/status/476084035174019072,http://twitter.com/mtmdphd
06/09/14,http://twitter.com/drcbsteer/status/476098197748604928,drcbsteer,RT @mtmdphd: Does It Matter Who Is the Doctor Who Performs Your Screening Colonoscopy? - via @ElaineSchattner @Forbes http://t.co/fbvdCgsuE…,6.991009,http://twitter.com/drcbsteer/status/476098197748604928,http://twitter.com/drcbsteer
06/09/14,http://twitter.com/fischmd/status/476098906313728000,fischmd,RT @mtmdphd: Does It Matter Who Is the Doctor Who Performs Your Screening Colonoscopy? - via @ElaineSchattner @Forbes http://t.co/fbvdCgsuE…,10.180483,http://twitter.com/fischmd/status/476098906313728000,http://twitter.com/fischmd
06/09/14,http://twitter.com/drbridgetobrien/status/476101901814366208,drbridgetobrien,RT @mtmdphd: Does It Matter Who Is the Doctor Who Performs Your Screening Colonoscopy? - via @ElaineSchattner @Forbes http://t.co/fbvdCgsuE…,6.991009,http://twitter.com/DrBridgetOBrien/status/476101901814366208,http://twitter.com/drbridgetobrien
06/09/14,http://twitter.com/onced/status/476106304113475584,onced,Download CRC mAPP-iPad App 4 #MedOncs w/ direct access to 70+ clinical trials in metastatic #ColorectalCancer http://t.co/AEM2CZ6Mxo #CRCSM,8.235214,http://twitter.com/OncEd/status/476106304113475584,http://twitter.com/onced
06/09/14,http://twitter.com/onacom/status/476148024977424384,onacom,How as treatment for gastrointestinal #cancer changed during the last 50 years? #pancsm #crcsm #esosm http://t.co/HKLCYnWcxE,7.109777,http://twitter.com/ONAcom/status/476148024977424384,http://twitter.com/onacom
06/10/14,http://twitter.com/mtmdphd/status/476394910179135489,mtmdphd,Merck to Collaborate with Sysmex Inostics on a Blood-Based RAS Biomarker Test http://t.co/w2qKctqCMf cc: @antonyruggeri #crcsm,10.778144,http://twitter.com/mtmdphd/status/476394910179135489,http://twitter.com/mtmdphd
06/10/14,http://twitter.com/twittmanda/status/476395052248207360,twittmanda,RT @mtmdphd: Merck to Collaborate with Sysmex Inostics on a Blood-Based RAS Biomarker Test http://t.co/w2qKctqCMf cc: @antonyruggeri #crcsm,6.802333,http://twitter.com/twittmanda/status/476395052248207360,http://twitter.com/twittmanda
06/10/14,http://twitter.com/subatomicdoc/status/476426073077710848,subatomicdoc,Does It Matter Who Is the Doctor Who Performs Your Screening Colonoscopy?  http://t.co/rUmNV4Q60i via @ElaineSchattner @forbes #crcsm,10.6553755,http://twitter.com/subatomicdoc/status/476426073077710848,http://twitter.com/subatomicdoc
06/10/14,http://twitter.com/onced/status/476438799065415680,onced,#ASCO14 video update: Dr. Scott Berry: OPUS and CRYSTAL Studies http://t.co/scWV5szwvh #CRCSM #MedOnc,7.31356,http://twitter.com/OncEd/status/476438799065415680,http://twitter.com/onced
06/10/14,http://twitter.com/granitehead/status/476449812754497536,granitehead,Report: Cost of cancer care treatment as availability of community oncology practices decrease #lcsm #bcsm #crcsm http://t.co/RYGhORbvlL,7.307612,http://twitter.com/granitehead/status/476449812754497536,http://twitter.com/granitehead
06/10/14,http://twitter.com/chemoadvisor/status/476479024655761408,chemoadvisor,"As Screening Increased, #ColorectalCancer Incidence Decreased #crcsm http://t.co/jHtinoHYaj",8.516493,http://twitter.com/ChemoAdvisor/status/476479024655761408,http://twitter.com/chemoadvisor
06/10/14,http://twitter.com/josico99/status/476487182111490048,josico99,"RT @ChemoAdvisor: As Screening Increased, #ColorectalCancer Incidence Decreased #crcsm http://t.co/jHtinoHYaj",7.4690995,http://twitter.com/josico99/status/476487182111490048,http://twitter.com/josico99
06/11/14,http://twitter.com/onced/status/476667106306428928,onced,#ASCO14 video update: RAINBOW Trial – Dr. Vincent Tam http://t.co/scWV5szwvh #CRCSM,7.490762,http://twitter.com/OncEd/status/476667106306428928,http://twitter.com/onced
06/11/14,http://twitter.com/luriecancer/status/476712952918441984,luriecancer,Study Illustrates Racial / Ethnic #Disparities in #ColonCancer Screening http://t.co/MvhS0nX18f via @NUFeinbergMed @NCICRCHD #crcsm,8.833356,http://twitter.com/LurieCancer/status/476712952918441984,http://twitter.com/luriecancer
06/11/14,http://twitter.com/twittmanda/status/476714676462428161,twittmanda,RT @LurieCancer: Study Illustrates Racial / Ethnic #Disparities in #ColonCancer Screening http://t.co/MvhS0nX18f via @NUFeinbergMed @NCICRC…,6.986464,http://twitter.com/twittmanda/status/476714676462428161,http://twitter.com/twittmanda
06/11/14,http://twitter.com/dmooneymd/status/476769973466329088,dmooneymd,Just watched oral abst #ASCO14 re: adj chemo for rectal ca #crcsm . ADORE and CONSORT both with sml abs 3 yr DFS ben to adding oxali to 5fu.,6.7181153,http://twitter.com/dmooneymd/status/476769973466329088,http://twitter.com/dmooneymd
06/11/14,http://twitter.com/dmooneymd/status/476770533095505921,dmooneymd,My 2cnts-oxali benefit also helps show overall benefit to adj chemo.  Higher abs benefit to oxali likely in higher stage dz. #ASCO14 #crcsm,6.712707,http://twitter.com/dmooneymd/status/476770533095505921,http://twitter.com/dmooneymd
06/12/14,http://twitter.com/scottrberry/status/476912647221571584,scottrberry,RT @OncEd: Download CRC mAPP-iPad App 4 #MedOncs w/ direct access to 70+ clinical trials in metastatic #ColorectalCancer http://t.co/AEM2CZ…,6.804326,http://twitter.com/scottrberry/status/476912647221571584,http://twitter.com/scottrberry
06/12/14,http://twitter.com/dmorarescu/status/476917363728580608,dmorarescu,RT @OncEd: Download CRC mAPP-iPad App 4 #MedOncs w/ direct access to 70+ clinical trials in metastatic #ColorectalCancer http://t.co/AEM2CZ…,6.804326,http://twitter.com/DMorarescu/status/476917363728580608,http://twitter.com/dmorarescu
06/12/14,http://twitter.com/cathyengmd/status/477039690667667456,cathyengmd,"#Colorectal #cancer screening should still be considered in pple  &gt; 75y/o, http://t.co/NjAEZame2v.  #crcsm, #endcancer",8.273078,http://twitter.com/CathyEngMD/status/477039690667667456,http://twitter.com/cathyengmd
06/12/14,http://twitter.com/onced/status/477072963464740865,onced,#ASCO14 video update: Dr. Scott Berry: OPUS and CRYSTAL Studies http://t.co/scWV5szwvh #CRCSM #MedOnc,7.37067,http://twitter.com/OncEd/status/477072963464740865,http://twitter.com/onced
06/12/14,http://twitter.com/oncologytimes/status/477158198558736384,oncologytimes,"Met colorectal cancer: Mab-containing regimens equivalent, so OK to choose by other factors http://t.co/eFzZ1OHHKk #ASCO14 #crcsm",11.449736,http://twitter.com/OncologyTimes/status/477158198558736384,http://twitter.com/oncologytimes
06/12/14,http://twitter.com/looking4unknown/status/477160767574122496,looking4unknown,"RT @OncologyTimes: Met colorectal cancer: Mab-containing regimens equivalent, so OK to choose by other factors http://t.co/eFzZ1OHHKk #ASCO…",6.899926,http://twitter.com/looking4unknown/status/477160767574122496,http://twitter.com/looking4unknown
06/12/14,http://twitter.com/bpelus/status/477167617049124864,bpelus,"RT @OncologyTimes: Met colorectal cancer: Mab-containing regimens equivalent, so OK to choose by other factors http://t.co/eFzZ1OHHKk #ASCO…",6.899926,http://twitter.com/BPELUS/status/477167617049124864,http://twitter.com/bpelus
06/13/14,http://twitter.com/onclive/status/477308152413581312,onclive,Experts discuss treatments available in the second- and later-line settings for patients with mCRC http://t.co/YyBMcA0P83 #crcsm,7.1611447,http://twitter.com/OncLive/status/477308152413581312,http://twitter.com/onclive
06/13/14,http://twitter.com/ascopost/status/477439624399163393,ascopost,Surveillance After Colon Cancer Surgery: Too Much of a Good Thing? http://t.co/2C8MlEoFVy #crcsm,12.844417,http://twitter.com/ASCOPost/status/477439624399163393,http://twitter.com/ascopost
06/13/14,http://twitter.com/marioivega/status/477451613141889024,marioivega,RT @ASCOPost: Surveillance After Colon Cancer Surgery: Too Much of a Good Thing? http://t.co/2C8MlEoFVy #crcsm,7.5366697,http://twitter.com/marioivega/status/477451613141889024,http://twitter.com/marioivega
06/13/14,http://twitter.com/dawnka/status/477454804835237888,dawnka,RT @ASCOPost: Surveillance After Colon Cancer Surgery: Too Much of a Good Thing? http://t.co/2C8MlEoFVy #crcsm,10.757213,http://twitter.com/DawnKA/status/477454804835237888,http://twitter.com/dawnka
06/14/14,http://twitter.com/mdandersonnews/status/477618939376435200,mdandersonnews,#Coloncancer caregiver: How helping my dad during #cancer treatment helped me http://t.co/H0cezigrtv #crcsm #endcancer,12.433179,http://twitter.com/MDAndersonNews/status/477618939376435200,http://twitter.com/mdandersonnews
06/14/14,http://twitter.com/nikala/status/477620836552024064,nikala,RT @MDAndersonNews: #Coloncancer caregiver: How helping my dad during #cancer treatment helped me http://t.co/H0cezigrtv #crcsm #endcancer,7.3743534,http://twitter.com/nikala/status/477620836552024064,http://twitter.com/nikala
06/14/14,http://twitter.com/ilatersa/status/477637333739515904,ilatersa,RT @ASCOPost: Surveillance After Colon Cancer Surgery: Too Much of a Good Thing? http://t.co/2C8MlEoFVy #crcsm,7.5366697,http://twitter.com/ilatersa/status/477637333739515904,http://twitter.com/ilatersa
06/14/14,http://twitter.com/77zanzibar/status/477807725531787264,77zanzibar,RT @MDAndersonNews: #Coloncancer caregiver: How helping my dad during #cancer treatment helped me http://t.co/H0cezigrtv #crcsm #endcancer,7.3743534,http://twitter.com/77zanzibar/status/477807725531787264,http://twitter.com/77zanzibar
06/15/14,http://twitter.com/wordsatspangalo/status/478041104273899521,wordsatspangalo,RT @ASCOPost: Surveillance After Colon Cancer Surgery: Too Much of a Good Thing? http://t.co/2C8MlEoFVy #crcsm,7.5366697,http://twitter.com/WordSatSpangalo/status/478041104273899521,http://twitter.com/wordsatspangalo
06/15/14,http://twitter.com/framul/status/478043940763881472,framul,RT @ASCOPost: Surveillance After Colon Cancer Surgery: Too Much of a Good Thing? http://t.co/2C8MlEoFVy #crcsm,7.5366697,http://twitter.com/framul/status/478043940763881472,http://twitter.com/framul
06/15/14,http://twitter.com/shewithlynch/status/478250616532115457,shewithlynch,RT @MDAndersonNews: #Coloncancer caregiver: How helping my dad during #cancer treatment helped me http://t.co/H0cezigrtv #crcsm #endcancer,7.3743534,http://twitter.com/ShewithLynch/status/478250616532115457,http://twitter.com/shewithlynch
06/16/14,http://twitter.com/shewithlynch/status/478385004183969792,shewithlynch,RT @LurieCancer: Study Illustrates Racial / Ethnic #Disparities in #ColonCancer Screening http://t.co/MvhS0nX18f via @NUFeinbergMed @NCICRC…,6.986464,http://twitter.com/ShewithLynch/status/478385004183969792,http://twitter.com/shewithlynch
06/16/14,http://twitter.com/hawkeyemisso/status/478386410919976960,hawkeyemisso,RT @LurieCancer: Study Illustrates Racial / Ethnic #Disparities in #ColonCancer Screening http://t.co/MvhS0nX18f via @NUFeinbergMed @NCICRC…,6.986464,http://twitter.com/HawkeyeMissO/status/478386410919976960,http://twitter.com/hawkeyemisso
06/16/14,http://twitter.com/cathyengmd/status/478389165650759680,cathyengmd,"Results of our randomized phase II trial of AMG-102, HGF MAb, in met #colorectal #cancer: http://t.co/RqS8hXuZ8u, #endcancer, #crcsm",7.002483,http://twitter.com/CathyEngMD/status/478389165650759680,http://twitter.com/cathyengmd
06/16/14,http://twitter.com/yzafar/status/478535465625452544,yzafar,"Rectal cancer R04 results: preop 5FU=cape, but be mindful of cost &amp; adherence (often non-issues on trial) http://t.co/97gddGZHkv #crcsm",7.7407646,http://twitter.com/yzafar/status/478535465625452544,http://twitter.com/yzafar
06/16/14,http://twitter.com/crcareindy/status/478595084137807872,crcareindy,RT @MDAndersonNews: #Coloncancer caregiver: How helping my dad during #cancer treatment helped me http://t.co/H0cezigrtv #crcsm #endcancer,7.3743534,http://twitter.com/CrcareINDY/status/478595084137807872,http://twitter.com/crcareindy
06/16/14,http://twitter.com/mjmbauti/status/478626889733791744,mjmbauti,"RT @yzafar: Rectal cancer R04 results: preop 5FU=cape, but be mindful of cost &amp; adherence (often non-issues on trial) http://t.co/97gddGZHk…",6.728627,http://twitter.com/mjmbauti/status/478626889733791744,http://twitter.com/mjmbauti
06/16/14,http://twitter.com/danafarber/status/478641922933018624,danafarber,50 years of discovery - advances in #colorectalcancer treatment: http://t.co/CiDWPPHdyV #crcsm,12.887621,http://twitter.com/DanaFarber/status/478641922933018624,http://twitter.com/danafarber
06/16/14,http://twitter.com/mduggan10/status/478642065010470912,mduggan10,RT @DanaFarber: 50 years of discovery - advances in #colorectalcancer treatment: http://t.co/CiDWPPHdyV #crcsm,7.3295326,http://twitter.com/mduggan10/status/478642065010470912,http://twitter.com/mduggan10
06/16/14,http://twitter.com/molecutools/status/478642261807210496,molecutools,RT @DanaFarber: 50 years of discovery - advances in #colorectalcancer treatment: http://t.co/CiDWPPHdyV #crcsm,7.3295326,http://twitter.com/Molecutools/status/478642261807210496,http://twitter.com/molecutools
06/16/14,http://twitter.com/tidegrad92/status/478667068112666625,tidegrad92,RT @DanaFarber: 50 years of discovery - advances in #colorectalcancer treatment: http://t.co/CiDWPPHdyV #crcsm,7.3295326,http://twitter.com/Tidegrad92/status/478667068112666625,http://twitter.com/tidegrad92
06/17/14,http://twitter.com/batzaidi/status/478743631197917184,batzaidi,RT @DanaFarber: 50 years of discovery - advances in #colorectalcancer treatment: http://t.co/CiDWPPHdyV #crcsm,7.3295326,http://twitter.com/BatZaidi/status/478743631197917184,http://twitter.com/batzaidi
06/17/14,http://twitter.com/lkafle/status/478749486512996353,lkafle,RT @DanaFarber: 50 years of discovery - advances in #colorectalcancer treatment: http://t.co/CiDWPPHdyV #crcsm,7.3295326,http://twitter.com/lkafle/status/478749486512996353,http://twitter.com/lkafle
06/17/14,http://twitter.com/dawnka/status/478898633895444480,dawnka,RT @DanaFarber: 50 years of discovery - advances in #colorectalcancer treatment: http://t.co/CiDWPPHdyV #crcsm,10.550076,http://twitter.com/DawnKA/status/478898633895444480,http://twitter.com/dawnka
06/17/14,http://twitter.com/onced/status/478905308383703040,onced,#ASCO14 video update: PANCREOX Trial – Dr. Vincent Tam http://t.co/scWV5szwvh #CRCSM,7.350698,http://twitter.com/OncEd/status/478905308383703040,http://twitter.com/onced
06/17/14,http://twitter.com/ventana/status/478915243952074752,ventana,Panelists discuss current trends in the treatment of colorectal cancer  http://t.co/nIxghjF7Wm @OncLive #crcsm,7.4621196,http://twitter.com/ventana/status/478915243952074752,http://twitter.com/ventana
06/17/14,http://twitter.com/onced/status/478986623221129216,onced,#ASCO14 video update: A phase III non-inferiority trial (AIO KRK 0207) – Dr. Dirk Arnold http://t.co/scWV5szwvh #CRCSM,7.7843966,http://twitter.com/OncEd/status/478986623221129216,http://twitter.com/onced
06/17/14,http://twitter.com/corp_unc/status/479018204577419266,corp_unc,"Patient navigation assoc'd w increased CRC screening / improved equity in vulnerable pts 
Percac-Lima et al http://t.co/3bwIa79Rs8 #crcsm",6.9339,http://twitter.com/corp_UNC/status/479018204577419266,http://twitter.com/corp_unc
06/17/14,http://twitter.com/danafarber/status/479040801042071554,danafarber,A look at the different #colorectalcancer screening options: http://t.co/WjijZm65sw #crcsm,12.863318,http://twitter.com/DanaFarber/status/479040801042071554,http://twitter.com/danafarber
06/17/14,http://twitter.com/ericberg5/status/479042028932956160,ericberg5,RT @DanaFarber: A look at the different #colorectalcancer screening options: http://t.co/WjijZm65sw #crcsm,7.6273775,http://twitter.com/EricBerg5/status/479042028932956160,http://twitter.com/ericberg5
06/17/14,http://twitter.com/cardiooncology/status/479044133005193218,cardiooncology,RT @DanaFarber: A look at the different #colorectalcancer screening options: http://t.co/WjijZm65sw #crcsm,7.6273775,http://twitter.com/CardioOncology/status/479044133005193218,http://twitter.com/cardiooncology
06/18/14,http://twitter.com/scottrberry/status/479213682875187200,scottrberry,RT @OncEd: #ASCO14 video update: A phase III non-inferiority trial (AIO KRK 0207) – Dr. Dirk Arnold http://t.co/scWV5szwvh #CRCSM,6.685676,http://twitter.com/scottrberry/status/479213682875187200,http://twitter.com/scottrberry
06/18/14,http://twitter.com/rnauditcom/status/479240060957499392,rnauditcom,RT @DanaFarber: A look at the different #colorectalcancer screening options: http://t.co/WjijZm65sw #crcsm,7.6273775,http://twitter.com/RNAuditcom/status/479240060957499392,http://twitter.com/rnauditcom
06/18/14,http://twitter.com/dawnka/status/479248878865096705,dawnka,RT @DanaFarber: A look at the different #colorectalcancer screening options: http://t.co/WjijZm65sw #crcsm,10.84792,http://twitter.com/DawnKA/status/479248878865096705,http://twitter.com/dawnka
06/18/14,http://twitter.com/onced/status/479301057453887489,onced,#ASCO14 video update: ACCENT Database – Dr. Daniel Sargent http://t.co/scWV5szwvh #CRCSM,9.097777,http://twitter.com/OncEd/status/479301057453887489,http://twitter.com/onced
06/18/14,http://twitter.com/luriecancer/status/479316631911673856,luriecancer,Reminders improve #coloncancer screening rates in low-income communities http://t.co/71YZrYbTD0 … @nu_ipham  @AHRQNews #crcsm,8.691389,http://twitter.com/LurieCancer/status/479316631911673856,http://twitter.com/luriecancer
06/18/14,http://twitter.com/nu_ipham/status/479318689741688833,nu_ipham,RT @LurieCancer: Reminders improve #coloncancer screening rates in low-income communities http://t.co/71YZrYbTD0 … @nu_ipham  @AHRQNews #cr…,6.825927,http://twitter.com/nu_ipham/status/479318689741688833,http://twitter.com/nu_ipham
06/18/14,http://twitter.com/mtmdphd/status/479322038067552256,mtmdphd,"Cancer Tag Ontology - @symplur http://t.co/MhLngrGUCW #crcsm #lcsm #mmsm etc...
@subatomicdoc comments: http://t.co/x2CWlgyU9v",10.134411,http://twitter.com/mtmdphd/status/479322038067552256,http://twitter.com/mtmdphd
06/18/14,http://twitter.com/osuccc_james/status/479330230327607297,osuccc_james,"Dr. Electra Paskett discusses how #colorectalcancer screenings are ""woefully underused."" http://t.co/GBO2oxZqbb #crcsm",11.523548,http://twitter.com/OSUCCC_James/status/479330230327607297,http://twitter.com/osuccc_james
06/18/14,http://twitter.com/k_basenengquist/status/479331549012566017,k_basenengquist,Too much #sitting linked to risk of developing endometrial and colon cancer. http://t.co/oM4QhGFpMR #sedentary #endcancer #CRCSM #GynCSM,9.234997,http://twitter.com/K_BasenEngquist/status/479331549012566017,http://twitter.com/k_basenengquist
06/18/14,http://twitter.com/100cunzhall/status/479334594215702528,100cunzhall,"RT @OSUCCC_James: Dr. Electra Paskett discusses how #colorectalcancer screenings are ""woefully underused."" http://t.co/GBO2oxZqbb #crcsm",7.055104,http://twitter.com/100CunzHall/status/479334594215702528,http://twitter.com/100cunzhall
06/18/14,http://twitter.com/groen_w/status/479334841402789888,groen_w,RT @K_BasenEngquist: Too much #sitting linked to risk of developing endometrial and colon cancer. http://t.co/oM4QhGFpMR #sedentary #endcan…,6.9409156,http://twitter.com/groen_w/status/479334841402789888,http://twitter.com/groen_w
06/18/14,http://twitter.com/dmgraymd/status/479346137963302912,dmgraymd,"RT @OSUCCC_James: Dr. Electra Paskett discusses how #colorectalcancer screenings are ""woefully underused."" http://t.co/GBO2oxZqbb #crcsm",7.055104,http://twitter.com/DMGrayMD/status/479346137963302912,http://twitter.com/dmgraymd
06/18/14,http://twitter.com/drbrigidmlynch/status/479395990248505344,drbrigidmlynch,RT @K_BasenEngquist: Too much #sitting linked to risk of developing endometrial and colon cancer. http://t.co/oM4QhGFpMR #sedentary #endcan…,6.9409156,http://twitter.com/drbrigidmlynch/status/479395990248505344,http://twitter.com/drbrigidmlynch
06/18/14,http://twitter.com/scottrberry/status/479410836919025664,scottrberry,RT @OncEd: #ASCO14 video update: ACCENT Database – Dr. Daniel Sargent http://t.co/scWV5szwvh #CRCSM,7.266059,http://twitter.com/scottrberry/status/479410836919025664,http://twitter.com/scottrberry
06/19/14,http://twitter.com/danafarber/status/479641009685794816,danafarber,50 years of discovery - advances in #colorectalcancer treatment: http://t.co/CiDWPPHdyV #crcsm,12.042261,http://twitter.com/DanaFarber/status/479641009685794816,http://twitter.com/danafarber
06/19/14,http://twitter.com/talkabouthealth/status/479651871972274176,talkabouthealth,"At higher risk of #colorectalcancer,what symptoms should they watch to inform doctor?Dr.Murff @VUMChealth
http://t.co/q9AQ7hZEBw #crcsm",10.414712,http://twitter.com/talkabouthealth/status/479651871972274176,http://twitter.com/talkabouthealth
06/19/14,http://twitter.com/alexisloustau/status/479656802033074176,alexisloustau,“@DanaFarber: 50 years of discovery - advances in #colorectalcancer treatment: http://t.co/8lOIFBDrhJ #crcsm”@DrFeito #ExSci2100,7.041275,http://twitter.com/AlexisLoustau/status/479656802033074176,http://twitter.com/alexisloustau
06/19/14,http://twitter.com/dawnka/status/479669908104433666,dawnka,RT @DanaFarber: 50 years of discovery - advances in #colorectalcancer treatment: http://t.co/CiDWPPHdyV #crcsm,10.596105,http://twitter.com/DawnKA/status/479669908104433666,http://twitter.com/dawnka
06/19/14,http://twitter.com/twittmanda/status/479695279180873728,twittmanda,RT @LurieCancer: Reminders improve #coloncancer screening rates in low-income communities http://t.co/71YZrYbTD0 … @nu_ipham  @AHRQNews #cr…,6.825927,http://twitter.com/twittmanda/status/479695279180873728,http://twitter.com/twittmanda
06/19/14,http://twitter.com/k_basenengquist/status/479725112942673920,k_basenengquist,"Female CRC survivors less prepared 4 physical, emotional sequelae after cancer care, comp to breast, prostate, male CRC. #CASurvConf #CRCSM",11.429729,http://twitter.com/K_BasenEngquist/status/479725112942673920,http://twitter.com/k_basenengquist
06/20/14,http://twitter.com/coffeemommy/status/479827185495072768,coffeemommy,@WillG3rd This article may help: http://t.co/sytwyuHVG3 and/or ask w/ #crcsm Also http://t.co/xJAdCn69CG site HTH! @DrAttai @subatomicdoc,11.627991,http://twitter.com/coffeemommy/status/479827185495072768,http://twitter.com/coffeemommy
06/20/14,http://twitter.com/myself_sam/status/479832648383496192,myself_sam,RT @coffeemommy: @WillG3rd This article may help: http://t.co/sytwyuHVG3 and/or ask w/ #crcsm Also http://t.co/xJAdCn69CG site HTH! @DrAtta…,10.283238,http://twitter.com/myself_sam/status/479832648383496192,http://twitter.com/myself_sam
06/20/14,http://twitter.com/health_ed/status/479964608179232768,health_ed,Introduction to Cancer: Focus on Solid Tumors SF Oct 22-23 Learn from leading physicians http://t.co/U6HMWDSJ3M #crcsm #bcsm #lcsm,7.1075397,http://twitter.com/Health_ed/status/479964608179232768,http://twitter.com/health_ed
06/20/14,http://twitter.com/ascopost/status/479972682478657536,ascopost,Surgical Treatment Delay May Not Result in Worse Outcomes in Patients With Colon Cancer http://t.co/h2untPqs0r #crcsm,12.992217,http://twitter.com/ASCOPost/status/479972682478657536,http://twitter.com/ascopost
06/20/14,http://twitter.com/aricaroline/status/479973181990907904,aricaroline,RT @ASCOPost: Surgical Treatment Delay May Not Result in Worse Outcomes in Patients With Colon Cancer http://t.co/h2untPqs0r #crcsm,7.522339,http://twitter.com/aricaroline/status/479973181990907904,http://twitter.com/aricaroline
06/20/14,http://twitter.com/fischmd/status/479973368851349504,fischmd,"RT @K_BasenEngquist: Female CRC survivors less prepared 4 physical, emotional sequelae after cancer care, comp to breast, prostate, male CR…",10.11656,http://twitter.com/fischmd/status/479973368851349504,http://twitter.com/fischmd
06/20/14,http://twitter.com/dawnka/status/479973461456977920,dawnka,RT @ASCOPost: Surgical Treatment Delay May Not Result in Worse Outcomes in Patients With Colon Cancer http://t.co/h2untPqs0r #crcsm,10.742882,http://twitter.com/DawnKA/status/479973461456977920,http://twitter.com/dawnka
06/20/14,http://twitter.com/jnci_now/status/479975209953267712,jnci_now,RT @ASCOPost: Surgical Treatment Delay May Not Result in Worse Outcomes in Patients With Colon Cancer http://t.co/h2untPqs0r #crcsm,7.522339,http://twitter.com/JNCI_Now/status/479975209953267712,http://twitter.com/jnci_now
06/20/14,http://twitter.com/hbtsociety/status/479980080303976448,hbtsociety,RT @ASCOPost: Surgical Treatment Delay May Not Result in Worse Outcomes in Patients With Colon Cancer http://t.co/h2untPqs0r #crcsm,7.522339,http://twitter.com/HbtSociety/status/479980080303976448,http://twitter.com/hbtsociety
06/20/14,http://twitter.com/oncologyadvance/status/479984454677852160,oncologyadvance,RT @ASCOPost: Surgical Treatment Delay May Not Result in Worse Outcomes in Patients With Colon Cancer http://t.co/4nfvTsTFcl #crcsm,7.4935837,http://twitter.com/OncologyAdvance/status/479984454677852160,http://twitter.com/oncologyadvance
06/20/14,http://twitter.com/lesleylesleys/status/479991249819430913,lesleylesleys,"RT @K_BasenEngquist: Female CRC survivors less prepared 4 physical, emotional sequelae after cancer care, comp to breast, prostate, male CR…",6.927087,http://twitter.com/LesleyLesleys/status/479991249819430913,http://twitter.com/lesleylesleys
06/20/14,http://twitter.com/subatomicdoc/status/479994718257164289,subatomicdoc,Outreach doubles colon cancer screening in low-income communities  http://t.co/6kmd8tXjwE &gt;@ScienceDaily @northwesternu #crcsm,12.374744,http://twitter.com/subatomicdoc/status/479994718257164289,http://twitter.com/subatomicdoc
06/20/14,http://twitter.com/ccchallengefdn/status/479996730449338368,ccchallengefdn,RT @DanaFarber: 50 years of discovery - advances in #colorectalcancer treatment: http://t.co/CiDWPPHdyV #crcsm,7.3755617,http://twitter.com/CCChallengeFdn/status/479996730449338368,http://twitter.com/ccchallengefdn
06/20/14,http://twitter.com/ventana/status/480002798713856000,ventana,50 years of discovery: Advances in #ColorectalCancer Treatment http://t.co/lDYYgiiEHZ #crcsm @DanaFarber,7.6429224,http://twitter.com/ventana/status/480002798713856000,http://twitter.com/ventana
06/20/14,http://twitter.com/timallenmdjd/status/480044634106638336,timallenmdjd,RT @subatomicdoc: Outreach doubles colon cancer screening in low-income communities  http://t.co/6kmd8tXjwE &gt;@ScienceDaily @northwesternu #…,10.324676,http://twitter.com/TimAllenMDJD/status/480044634106638336,http://twitter.com/timallenmdjd
06/21/14,http://twitter.com/willg3rd/status/480181340948549633,willg3rd,RT @coffeemommy: @WillG3rd This article may help: http://t.co/sytwyuHVG3 and/or ask w/ #crcsm Also http://t.co/xJAdCn69CG site HTH! @DrAtta…,7.1146145,http://twitter.com/WillG3rd/status/480181340948549633,http://twitter.com/willg3rd
06/21/14,http://twitter.com/crispincvicente/status/480259828070506496,crispincvicente,RT @ASCOPost: Surgical Treatment Delay May Not Result in Worse Outcomes in Patients With Colon Cancer http://t.co/h2untPqs0r #crcsm,7.522339,http://twitter.com/CrispinCVicente/status/480259828070506496,http://twitter.com/crispincvicente
06/21/14,http://twitter.com/corp_unc/status/480333102569758720,corp_unc,"Rural-Urban Diff. in Access to Specialist Providers of CRC Care in the US
http://t.co/zwJ8RUmMj2 @jhayanga et al
#workforce #crcsm",7.1207843,http://twitter.com/corp_UNC/status/480333102569758720,http://twitter.com/corp_unc
06/21/14,http://twitter.com/talkabouthealth/status/480483342303764480,talkabouthealth,"In what situations for early stage #coloncancer is radiation therapy an option? Dr.Liauw @UChicagoMed
http://t.co/0dqdVHzyb1 #crcsm",11.686222,http://twitter.com/talkabouthealth/status/480483342303764480,http://twitter.com/talkabouthealth
06/22/14,http://twitter.com/ilatersa/status/480510756631220224,ilatersa,RT @ASCOPost: Surgical Treatment Delay May Not Result in Worse Outcomes in Patients With Colon Cancer http://t.co/h2untPqs0r #crcsm,7.522339,http://twitter.com/ilatersa/status/480510756631220224,http://twitter.com/ilatersa
06/22/14,http://twitter.com/cancerlikeme/status/480811547410071553,cancerlikeme,"MT “@jamie_love: Google hits for ""sovaldi price"": about 143,000 results.  ""Cancer drug price"": About 66,800,000 results” #lcsm #bcsm #crcsm",6.985742,http://twitter.com/cancerlikeme/status/480811547410071553,http://twitter.com/cancerlikeme
06/23/14,http://twitter.com/glenmjones/status/481055911553667073,glenmjones,"RT @talkabouthealth: In what situations for early stage #coloncancer is radiation therapy an option? Dr.Liauw @UChicagoMed
http://t.co/0dqd…",7.102886,http://twitter.com/glenmjones/status/481055911553667073,http://twitter.com/glenmjones
06/23/14,http://twitter.com/ascopost/status/481067375799050240,ascopost,Dr Alok Khorana on Understanding the Impact of Results From CALGB/SWOG 80405 in Colorectal Cancer http://t.co/DzRC5AxxGt #crcsm #ASCO14,12.155483,http://twitter.com/ASCOPost/status/481067375799050240,http://twitter.com/ascopost
06/23/14,http://twitter.com/asco/status/481180508140109824,asco,“Calcium &amp; Milk Tied to Higher Overall Survival among People w/ Colorectal Cancer” http://t.co/J1HfWqEpqA #crcsm #JCO,12.950115,http://twitter.com/ASCO/status/481180508140109824,http://twitter.com/asco
06/23/14,http://twitter.com/natedahlpharmd/status/481183285209354241,natedahlpharmd,RT @ASCO: “Calcium &amp; Milk Tied to Higher Overall Survival among People w/ Colorectal Cancer” http://t.co/jj7vR8L5Ro #crcsm #JCO,7.1479,http://twitter.com/NateDahlPharmD/status/481183285209354241,http://twitter.com/natedahlpharmd
06/23/14,http://twitter.com/urbano_anido/status/481187442209607680,urbano_anido,RT @ASCO: “Calcium &amp; Milk Tied to Higher Overall Survival among People w/ Colorectal Cancer” http://t.co/J1HfWqEpqA #crcsm #JCO,7.1146145,http://twitter.com/urbano_anido/status/481187442209607680,http://twitter.com/urbano_anido
06/23/14,http://twitter.com/timeo_danaos/status/481189945240199169,timeo_danaos,RT @ASCO: “Calcium &amp; Milk Tied to Higher Overall Survival among People w/ Colorectal Cancer” http://t.co/J1HfWqEpqA #crcsm #JCO,7.1146145,http://twitter.com/Timeo_Danaos/status/481189945240199169,http://twitter.com/timeo_danaos
06/23/14,http://twitter.com/cancerassassin1/status/481198093266726912,cancerassassin1,RT @ASCO: “Calcium &amp; Milk Tied to Higher Overall Survival among People w/ Colorectal Cancer” http://t.co/J1HfWqEpqA #crcsm #JCO,7.1146145,http://twitter.com/cancerassassin1/status/481198093266726912,http://twitter.com/cancerassassin1
06/23/14,http://twitter.com/tyrone_dinky/status/481207354764308480,tyrone_dinky,RT @ASCO: “Calcium &amp; Milk Tied to Higher Overall Survival among People w/ Colorectal Cancer” http://t.co/J1HfWqEpqA #crcsm #JCO,7.1146145,http://twitter.com/tyrone_dinky/status/481207354764308480,http://twitter.com/tyrone_dinky
06/23/14,http://twitter.com/anastasia_runs/status/481217196241477633,anastasia_runs,RT @ASCO: “Calcium &amp; Milk Tied to Higher Overall Survival among People w/ Colorectal Cancer” http://t.co/J1HfWqEpqA #crcsm #JCO,7.1146145,http://twitter.com/Anastasia_Runs/status/481217196241477633,http://twitter.com/anastasia_runs
06/23/14,http://twitter.com/hcaoncnursenav/status/481218706891345920,hcaoncnursenav,RT @ASCO: “Calcium &amp; Milk Tied to Higher Overall Survival among People w/ Colorectal Cancer” http://t.co/J1HfWqEpqA #crcsm #JCO,7.1146145,http://twitter.com/HCAOncNurseNav/status/481218706891345920,http://twitter.com/hcaoncnursenav
06/24/14,http://twitter.com/passage_blanc/status/481236599699542017,passage_blanc,RT @ASCO: “Calcium &amp; Milk Tied to Higher Overall Survival among People w/ Colorectal Cancer” http://t.co/J1HfWqEpqA #crcsm #JCO,7.1146145,http://twitter.com/passage_blanc/status/481236599699542017,http://twitter.com/passage_blanc
06/24/14,http://twitter.com/medzineapp/status/481437034075414529,medzineapp,Death rates remain higher for African-Americans with #coloncancer http://t.co/SKJ8HrHGwC #CRCSM #RectalCancer,7.30914,http://twitter.com/Medzineapp/status/481437034075414529,http://twitter.com/medzineapp
06/24/14,http://twitter.com/onced/status/481445990646308864,onced,#ASCO14 video update: Dr. Scott Berry: OPUS and CRYSTAL Studies http://t.co/scWV5szwvh #CRCSM #MedOnc,8.21149,http://twitter.com/OncEd/status/481445990646308864,http://twitter.com/onced
06/24/14,http://twitter.com/cafewo/status/481447247486283776,cafewo,RT @OncEd: #ASCO14 video update: Dr. Scott Berry: OPUS and CRYSTAL Studies http://t.co/scWV5szwvh #CRCSM #MedOnc,7.1623883,http://twitter.com/cafewo/status/481447247486283776,http://twitter.com/cafewo
06/24/14,http://twitter.com/talkabouthealth/status/481456492134936576,talkabouthealth,Are there models used to measure quality of care of  #colorectalcancer patient?Are measurements used? @yzafar http://t.co/4JLbucOeXg #crcsm,10.295999,http://twitter.com/talkabouthealth/status/481456492134936576,http://twitter.com/talkabouthealth
06/25/14,http://twitter.com/ascopost/status/481784946613174273,ascopost,Synthetic Triterpenoids Show Promise in Preventing Colitis-Associated Colon Cancer in Preclinical Study http://t.co/bHyIZJKn8a #crcsm,12.103348,http://twitter.com/ASCOPost/status/481784946613174273,http://twitter.com/ascopost
06/25/14,http://twitter.com/aricaroline/status/481785910657159170,aricaroline,RT @ASCOPost: Synthetic Triterpenoids Show Promise in Preventing Colitis-Associated Colon Cancer in Preclinical Study http://t.co/bHyIZJKn8…,6.9498715,http://twitter.com/aricaroline/status/481785910657159170,http://twitter.com/aricaroline
06/25/14,http://twitter.com/jnci_now/status/481791046297608192,jnci_now,RT @ASCOPost: Synthetic Triterpenoids Show Promise in Preventing Colitis-Associated Colon Cancer in Preclinical Study http://t.co/bHyIZJKn8…,6.9498715,http://twitter.com/JNCI_Now/status/481791046297608192,http://twitter.com/jnci_now
06/25/14,http://twitter.com/heckelme/status/481796431691272192,heckelme,RT @ASCOPost: Synthetic Triterpenoids Show Promise in Preventing Colitis-Associated Colon Cancer in Preclinical Study http://t.co/bHyIZJKn8…,6.9498715,http://twitter.com/heckelme/status/481796431691272192,http://twitter.com/heckelme
06/25/14,http://twitter.com/marioivega/status/481804759662223361,marioivega,RT @ASCOPost: Synthetic Triterpenoids Show Promise in Preventing Colitis-Associated Colon Cancer in Preclinical Study http://t.co/bHyIZJKn8…,6.9498715,http://twitter.com/marioivega/status/481804759662223361,http://twitter.com/marioivega
06/25/14,http://twitter.com/oncnursingnews/status/481824282742226946,oncnursingnews,"Study sheds light on racial disparity in colon cancer via @UMCancerCenter 
 http://t.co/7283DymQES #crcsm",7.528135,http://twitter.com/OncNursingNews/status/481824282742226946,http://twitter.com/oncnursingnews
06/25/14,http://twitter.com/onacom/status/481882215748759552,onacom,"RT @OncNursingNews: Study sheds light on racial disparity in colon cancer via @UMCancerCenter 
 http://t.co/hKfVU8TeLZ #crcsm",7.2227373,http://twitter.com/ONAcom/status/481882215748759552,http://twitter.com/onacom
06/26/14,http://twitter.com/fischmd/status/482136099771678720,fischmd,RT @ASCO: “Calcium &amp; Milk Tied to Higher Overall Survival among People w/ Colorectal Cancer” http://t.co/J1HfWqEpqA #crcsm #JCO,10.304088,http://twitter.com/fischmd/status/482136099771678720,http://twitter.com/fischmd
06/26/14,http://twitter.com/ascopost/status/482145860294561792,ascopost,Synthetic Triterpenoids Show Promise in Preventing Colitis-Associated Colon Cancer in Preclinical Study http://t.co/MEMrQ46E56 #crcsm,10.326322,http://twitter.com/ASCOPost/status/482145860294561792,http://twitter.com/ascopost
06/26/14,http://twitter.com/ascopost/status/482147822549336064,ascopost,"Combined w/Chemo, Cetuximab and Bevacizumab Comparable for 1st-Line Metastatic Colorectal Cancer Rx http://t.co/n0BqfUp37S #crcsm #ASCO14",10.821441,http://twitter.com/ASCOPost/status/482147822549336064,http://twitter.com/ascopost
06/26/14,http://twitter.com/physrelations/status/482150753478668288,physrelations,RT @ASCO: “Calcium &amp; Milk Tied to Higher Overall Survival among People w/ Colorectal Cancer” http://t.co/l7sU2c1gRu #crcsm #JCO,7.1146145,http://twitter.com/PhysRelations/status/482150753478668288,http://twitter.com/physrelations
06/26/14,http://twitter.com/mtmdphd/status/482157577526968320,mtmdphd,MT @disparityreport: New clues about why Blacks fare worse with #coloncancer http://t.co/CWmPnzvPph #crcsm,10.729835,http://twitter.com/mtmdphd/status/482157577526968320,http://twitter.com/mtmdphd
06/26/14,http://twitter.com/marioivega/status/482171317433544705,marioivega,"RT @ASCOPost: Combined w/Chemo, Cetuximab and Bevacizumab Comparable for 1st-Line Metastatic Colorectal Cancer Rx http://t.co/n0BqfUp37S #c…",6.8242774,http://twitter.com/marioivega/status/482171317433544705,http://twitter.com/marioivega
06/26/14,http://twitter.com/onced/status/482192151560740866,onced,Follow-up in #ColorectalCancer Patients Using CEA - Dr. Charlotte Verberne http://t.co/NjPkOYwbNc #Oncology #CRCSM,7.06186,http://twitter.com/OncEd/status/482192151560740866,http://twitter.com/onced
06/26/14,http://twitter.com/onced/status/482261752797622272,onced,#ASCO14 video update: PANCREOX Trial – Dr. Vincent Tam http://t.co/scWV5szwvh #CRCSM,8.8186865,http://twitter.com/OncEd/status/482261752797622272,http://twitter.com/onced
06/26/14,http://twitter.com/sethbla/status/482278489836376065,sethbla,MT @subatomicdoc: Doubling colon cancer screening in low-income communities  http://t.co/Xzv8yFuhgh &amp;gt;@ScienceDaily @northwesternu #crcsm,7.121196,http://twitter.com/SethBla/status/482278489836376065,http://twitter.com/sethbla
06/26/14,http://twitter.com/onced/status/482285061371203584,onced,Download CRC mAPP-iPad App 4 #MedOncs w/ direct access to 70+ clinical trials in metastatic #ColorectalCancer http://t.co/AEM2CZ6Mxo #CRCSM,8.902233,http://twitter.com/OncEd/status/482285061371203584,http://twitter.com/onced
06/27/14,http://twitter.com/onced/status/482529284959899649,onced,#ASCO14 video update: A phase III non-inferiority trial (AIO KRK 0207) – Dr. Dirk Arnold http://t.co/scWV5szwvh #CRCSM,8.471832,http://twitter.com/OncEd/status/482529284959899649,http://twitter.com/onced
06/27/14,http://twitter.com/dmorarescu/status/482534120942469120,dmorarescu,RT @OncEd: #ASCO14 video update: A phase III non-inferiority trial (AIO KRK 0207) – Dr. Dirk Arnold http://t.co/scWV5szwvh #CRCSM,6.7387056,http://twitter.com/DMorarescu/status/482534120942469120,http://twitter.com/dmorarescu
06/27/14,http://twitter.com/cathyengmd/status/482662065249591297,cathyengmd,"Can a FitBit help your pts increase their exercise? I hope so! I recommend it to many of my pts, #crcsm, #endcancer: http://t.co/4tXBzDxme2",11.750337,http://twitter.com/CathyEngMD/status/482662065249591297,http://twitter.com/cathyengmd
06/28/14,http://twitter.com/mkmackey/status/482688142936244224,mkmackey,"RT @CathyEngMD: Can a FitBit help your pts increase their exercise? I hope so! I recommend it to many of my pts, #crcsm, #endcancer: http:/…",10.480602,http://twitter.com/mkmackey/status/482688142936244224,http://twitter.com/mkmackey
06/28/14,http://twitter.com/sectionsix/status/482728036794896385,sectionsix,"RT @CathyEngMD: Can a FitBit help your pts increase their exercise? I hope so! I recommend it to many of my pts, #crcsm, #endcancer: http:/…",7.166243,http://twitter.com/sectionsix/status/482728036794896385,http://twitter.com/sectionsix
06/28/14,http://twitter.com/onced/status/482889501766078465,onced,#ASCO14 video update: Dr. Scott Berry: OPUS and CRYSTAL Studies http://t.co/YTuTKhtLgU #CRCSM #MedOnc,7.382143,http://twitter.com/OncEd/status/482889501766078465,http://twitter.com/onced
06/28/14,http://twitter.com/scottrberry/status/482891310706085889,scottrberry,RT @OncEd: Download CRC mAPP-iPad App 4 #MedOncs w/ direct access to 70+ clinical trials in metastatic #ColorectalCancer http://t.co/AEM2CZ…,6.7014003,http://twitter.com/scottrberry/status/482891310706085889,http://twitter.com/scottrberry
06/28/14,http://twitter.com/scottrberry/status/482891358126878720,scottrberry,RT @OncEd: #ASCO14 video update: PANCREOX Trial – Dr. Vincent Tam http://t.co/scWV5szwvh #CRCSM,7.012253,http://twitter.com/scottrberry/status/482891358126878720,http://twitter.com/scottrberry
06/28/14,http://twitter.com/parvathanenink/status/482946585148407810,parvathanenink,RT @ASCOPost: Synthetic Triterpenoids Show Promise in Preventing Colitis-Associated Colon Cancer in Preclinical Study http://t.co/bHyIZJKn8…,6.9498715,http://twitter.com/ParvathaneniNK/status/482946585148407810,http://twitter.com/parvathanenink
06/28/14,http://twitter.com/talkabouthealth/status/483028879506821121,talkabouthealth,What are treatment options for metastatic colorectal cancer that has spread to the lungs?Dr.Hochster @YaleMed http://t.co/9wsEE8mL6a #crcsm,11.145023,http://twitter.com/talkabouthealth/status/483028879506821121,http://twitter.com/talkabouthealth
06/29/14,http://twitter.com/marneycakes/status/483038008820523008,marneycakes,RT @OncEd: Download CRC mAPP-iPad App 4 #MedOncs w/ direct access to 70+ clinical trials in metastatic #ColorectalCancer http://t.co/AEM2CZ…,6.7014003,http://twitter.com/Marneycakes/status/483038008820523008,http://twitter.com/marneycakes
06/29/14,http://twitter.com/natedahlpharmd/status/483079222957572096,natedahlpharmd,RT @talkabouthealth: What are treatment options for metastatic colorectal cancer that has spread to the lungs?Dr.Hochster @YaleMed http://t…,7.0039954,http://twitter.com/NateDahlPharmD/status/483079222957572096,http://twitter.com/natedahlpharmd
06/29/14,http://twitter.com/markaorourke/status/483267426612953088,markaorourke,Milking the Evidence: Diet Does Matter http://t.co/NiJRnHwqgU #Cancer is a weed in the garden.  I like it. #swogonc #crcsm,7.5787134,http://twitter.com/markaorourke/status/483267426612953088,http://twitter.com/markaorourke
06/29/14,http://twitter.com/markaorourke/status/483267792389799936,markaorourke,Milking the Evidence: Diet Does Matter http://t.co/NiJRnHwqgU Refer #cancersurvivors for diet and lifestyle counseling. #swogonc #crcsm,7.3500447,http://twitter.com/markaorourke/status/483267792389799936,http://twitter.com/markaorourke
06/29/14,http://twitter.com/talkabouthealth/status/483346686094221312,talkabouthealth,What is meaning if patient has lowered blood counts while taking chemotherapy?Next steps?Dr.Hochster @YaleMed http://t.co/70IizI2jlU #crcsm,10.257945,http://twitter.com/talkabouthealth/status/483346686094221312,http://twitter.com/talkabouthealth
06/30/14,http://twitter.com/jedipd/status/483583702996627456,jedipd,Refractory mCRC (metastatic colon cancers) respond to TAS-102 trifluridine(FTD) &amp; tipiracil hydrochloride(TPI) #crcsm http://t.co/rU77vRJ1jg,9.90829,http://twitter.com/JediPD/status/483583702996627456,http://twitter.com/jedipd
06/30/14,http://twitter.com/health_ed/status/483585813255847936,health_ed,"Introduction to Cancer: Focus on Solid Tumors, 21-22 May, SF, CA. Includes #crcsm #pcsm #melsm. More info/booking at http://t.co/PhqnYM5Uo9",7.06186,http://twitter.com/Health_ed/status/483585813255847936,http://twitter.com/health_ed
06/30/14,http://twitter.com/prime_oncology/status/483670897849798657,prime_oncology,News from Barcelona: Phase 3 Study of Regorafenib Monotherapy in asian pts w/ previously treated mCRC #crcsm http://t.co/88ipzAxxhN,8.741826,http://twitter.com/prIME_Oncology/status/483670897849798657,http://twitter.com/prime_oncology
06/30/14,http://twitter.com/prime_oncology/status/483681296452177920,prime_oncology,Latest data on colorectal cancer from the 2014 Gastrointestinal Cancer Meeting in Barcelona #crcsm  http://t.co/nLKfMnO2BR,9.7642355,http://twitter.com/prIME_Oncology/status/483681296452177920,http://twitter.com/prime_oncology
06/30/14,http://twitter.com/natedahlpharmd/status/483687768782954496,natedahlpharmd,RT @prIME_Oncology: News from Barcelona: Phase 3 Study of Regorafenib Monotherapy in asian pts w/ previously treated mCRC #crcsm http://t.c…,7.016333,http://twitter.com/NateDahlPharmD/status/483687768782954496,http://twitter.com/natedahlpharmd
06/30/14,http://twitter.com/bmassutis/status/483689250995834880,bmassutis,RT @prIME_Oncology: Latest data on colorectal cancer from the 2014 Gastrointestinal Cancer Meeting in Barcelona #crcsm  http://t.co/nLKfMnO…,7.488864,http://twitter.com/bmassutis/status/483689250995834880,http://twitter.com/bmassutis
06/30/14,http://twitter.com/onced/status/483694284671942656,onced,#ASCO14 video update: PANCREOX Trial – Dr. Vincent Tam http://t.co/scWV5szwvh #CRCSM,7.236328,http://twitter.com/OncEd/status/483694284671942656,http://twitter.com/onced
06/30/14,http://twitter.com/francescxavierp/status/483699276263223296,francescxavierp,RT @prIME_Oncology: Latest data on colorectal cancer from the 2014 Gastrointestinal Cancer Meeting in Barcelona #crcsm  http://t.co/nLKfMnO…,7.488864,http://twitter.com/francescxavierp/status/483699276263223296,http://twitter.com/francescxavierp
06/30/14,http://twitter.com/francescxavierp/status/483699329014972417,francescxavierp,Latest data on colorectal cancer from the 2014 Gastrointestinal Cancer Meeting in Barcelona #crcsm  http://t.co/mGUt1R4uqh,7.7223186,http://twitter.com/francescxavierp/status/483699329014972417,http://twitter.com/francescxavierp
06/30/14,http://twitter.com/cathyengmd/status/483721593340694528,cathyengmd,"Phase III TAS-102 study for met colorectal shows improved OS, 7.1 vs. 5.3M (HR = 0.68), #crcsm, #endcancer, http://t.co/W05BkALFQJ",7.0592895,http://twitter.com/CathyEngMD/status/483721593340694528,http://twitter.com/cathyengmd
07/01/14,http://twitter.com/aakonc/status/483773775570161664,aakonc,"Interesting esp incl non Asian pop@CathyEngMD: TAS-102 study for met crc improves OS, 7.1 vs. 5.3M #crcsm http://t.co/7SuIImiKcD""",7.0258436,http://twitter.com/aakonc/status/483773775570161664,http://twitter.com/aakonc
